Our executive compensation program is reviewed each year for alignment with our business strategy and evolving market and governance practices for executive compensation.
Our compensation program consists of a balance of multiple elements, including base salary, annual cash incentive programs, and, for some employees, long-term equity incentive awards that are earned over a number of years. The structure of our annual cash incentives for NEOs includes multiple performance measures that are objective and quantifiable, with a corresponding minimum and maximum payout range. A significant portion of our NEOs’ pay is tied to long-term equity awards based on the achievement of predetermined financial and operational performance measures that we believe align the long-term interests of our executives with those of our stockholders.
After considering compensation within our peer group and consulting with Exequity, the Compensation Committee (the “Committee”) independently assessed the value and competitiveness of each NEO’s compensation, including various pay components. Based upon their assessment, the Board and the Committee made the following decisions regarding the framework for the 2019 executive compensation program:
Base Salary. The Committee reviewed the salaries of our CEO and other NEOs and determined that their current salaries were in alignment with the corresponding median levels of our peer data and competitive pay practices, and as a result, salaries for our CEO and other NEOs were not changed for 2019.
Annual Incentive Program. The Committee maintained the target bonus percentage for Mr. Griess at 150% of base salary. The target bonus percentages for the other NEOs were also maintained by the Committee with Mr. Kennedy’s and Mr. Shepherd’s targets remaining at 100% of base salary and Mr. Johns’ target remaining at 75% of base salary. For more information, see 2019 Compensation – 2019 Annual Performance Bonuses.
Long-Term Incentive (“LTI”) Program. For the 2019 annual grant, the Committee retained the LTI award program structure with 60% of each NEO’s award granted in the form of performance-based restricted stock, with the remaining 40% of each NEO’s 2019 LTI award granted in the form of time-based restricted stock that vests ratably over a four-year period.
Sixty percent of our CEO’s and on average 54% of our other NEOs’ total target compensation was based on the achievement of key financial and operational measures under our annual incentive and LTI programs.
We executed on our key strategic initiatives during 2019 and exceeded or met our financial targets. As a result, our NEOs’ achieved payouts and performance-based stock vesting under our executive compensation program are as follows:
Over 93% of the votes cast on our 2019 say-on-pay proposal were in favor of our executive compensation program and policies. When making compensation decisions for our NEOs, the Committee considers the voting results of our annual say-on-pay proposal along with other factors, such as our pay-for-performance philosophy and a competitive market analysis of peer companies to determine compensation practices. The Committee considered the results of the 2019 advisory vote in making changes to the 2019 compensation for our NEOs as described in this proxy statement.
We believe that the following governance and compensation practices reinforce our business strategy, culture, and values.
We Design Performance-Based Compensation to Reflect Our Business Strategy and Enhance Stockholder Value. We use certain predetermined financial and operational performance measures to determine compensation under our annual incentive and LTI programs. Each measure represents a key metric that reflects on the execution of our long-term business strategy to enhance stockholder value. For additional information about our business strategy, see the Company Overview and Business Strategy section.
We Emphasize the Long Term. A significant portion of our NEOs’ total compensation is in the form of long-term equity awards, 60% of which is performance-based restricted stock that fully vests only if we achieve specific predetermined financial or operational measures.
We Align the Financial Interests of Our Executives With the Interests of Our Stockholders Through Equity Awards and Share Ownership Guidelines. Each NEO must own at least the threshold level of our shares that is consistent with our share ownership guidelines. For additional information, see the Share Ownership Guidelines section.
We Have a Clawback Policy That Covers Our Executive Officers. The policy authorizes us to reduce or cancel, or require the recovery of, all or a portion of an executive officer’s annual bonus or LTI compensation award for intentional misconduct that leads to a material restatement of the financial statements of the Company. For additional information, see the Employment Agreements section.
No Potential Income Tax Gross-Ups. A key feature of the executive officers’ employment agreements is the exclusion of potential income tax gross-ups for change of control benefits. For additional information regarding the agreements, see the Employment Agreements section.
We Provide Only Limited Perquisites and Other Benefits. Our NEOs are generally eligible for few perquisites or other benefits outside those available to our employees. For additional information, see the 2019 Summary Compensation Table in the Executive Compensation Tables section.
No Dividends or Dividend Equivalents Paid on Unvested Stock Awards. We do not pay dividends or dividend equivalents on unvested stock awards. Dividends or dividend equivalents accrue, but are not paid on unvested performance- and time-based restricted stock awards. Accrued dividends are only paid upon vesting of restricted stock awards.
Each year during its February meeting, the Committee certifies the following for the previous fiscal year: (1) the level of performance attained for our predetermined performance measures; (2) the amount payable under the Annual Performance Bonus Program, our annual incentive program; and (3) the vesting levels for our performance-based restricted stock awards. The Committee also evaluates and recommends to the Board the base salary for each of our NEOs as well as the performance measures and target levels for the Annual Performance Bonus Program and performance-based restricted stock awards for the current year. The target levels are typically established based upon our initial internal financial or operational targets and adjusted for a pre-established growth or improvement factor for performance-based restricted stock awards that extend over a multi-year period.
When making compensation decisions and recommendations, the Committee considers the following key factors:
As required by the Committee’s charter, the CEO may not be present when either the Committee or the Board discuss or vote on CEO compensation.
The Committee undertakes considerable analysis when determining measures to be used in both its Annual Performance Bonus Program and performance-based equity awards.
The Committee selects a combination of measures that, if achieved in the long-term, will most likely result in positive long-term stockholder return. Goals are established to effectively incent the NEOs to achieve long-term results while maintaining the consistent operational excellence our customers have come to expect.
Our performance-based equity awards to our NEOs employ a multiple-year time horizon, with the shares in the award eligible for vesting based upon achievement of the specified predetermined objective and measurable performance levels. A minimum threshold of achievement is required before any shares for a measure may vest. At the threshold performance level, 50% of the target shares will vest. If targets are achieved, 100% of the target shares will vest. Up to 200% of the target shares may vest at the end of the performance period if targets are significantly exceeded.
The Committee believes that executive compensation based on the achievement of performance-based measures that are tied to the short- and long-term strategy of our business incentivizes management to invest in the success of the business, while also linking executive compensation to increasing stockholder value.
The Committee has sole authority and discretion to retain and terminate compensation consultants, independent legal counsel, and other advisers to help the Committee perform its responsibilities. It has the sole authority to approve the fees, scope, and other terms of engagement with its compensation consultant and other advisers, with full funding provided by the Company. The Committee is responsible for determining the independence of its compensation consultant and other advisers. Management is available at the Committee’s request to assist the consultant by providing historical pay data and perspective on our competitive environment for recruiting managerial talent.
Total Direct Compensation. The charts below illustrate the percentage of compensation our CEO and other NEOs on average would generally receive, if paid at target level, for each core compensation component, based on 2019 target compensation:
To assist the Committee in establishing 2019 compensation for the NEOs, Exequity provided a competitive assessment using peer group compensation information for the primary elements of our NEO compensation packages. Exequity analyzed and assessed peer group data for roles corresponding to and closely aligned to the roles of our NEOs. The peer group composition is described in the next section.
The Committee recognizes that peer group comparisons may not be perfectly aligned because the executive titles and responsibilities at peer group companies may not be directly comparable to those of our NEOs with similar or equivalent titles. The Committee generally considers Total Direct Compensation (including target bonus) for a NEO to be competitive if it is near the median of the peer group data.
Our compensation philosophy is intended to ensure leadership continuity as part of our succession planning and to leverage variable incentive pay tied to our performance.
The peer group used for compensation benchmarking is reviewed annually to ensure its composition and characteristics remain consistent with our objectives, and is based on analysis and recommendations by our independent compensation consultant. The peer group used to determine 2019 compensation, as listed in the following table, includes companies in the software, data processing and outsourced services, information technology consulting, and other electronic industries, which were selected for their comparable size, product, service offerings, customers, and markets. Their annual revenues ranged in size from $345 million to $2.0 billion at the end of 2018.
The Committee provides for competitive base compensation that reflects the scope of responsibility, level of authority, and overall duties of the position. Based on their review and assessment of the peer data and competitive market practices for the duties and responsibilities of each position, the Committee determined that the 2018 salary levels for our NEOs would be maintained for 2019 and no changes were made.
Annual performance bonuses are awarded under the terms of our Annual Performance Bonus Program and are determined based on the following formula:
Base Salary. The starting point for each NEO’s bonus calculation is the NEO’s base salary.
NEO Target Bonus Percentage. The Committee provides competitive bonus opportunities for the NEOs based on the achievement of annual performance goals. After considering the competitive compensation information provided by Exequity, the Committee elected to maintain a 150% target bonus percentage for Mr. Griess, a 100% target bonus percentage for Mr. Kennedy and Mr. Shepherd, and a 75% target bonus percentage for Mr. Johns for 2019.
The 2019 and 2018 target bonus percentages of base salary for each NEO were as follows:
The Company’s performance percentage achieved for 2019 for the results in the above table was calculated at 145.7% and was certified by the Committee in February 2020.
NEO Individual Performance Percentage. The final component of the Annual Performance Bonus Program is a determination by the Committee in its evaluation of each NEO’s individual performance achievement expressed as a percentage, not to exceed 100%. This evaluation is based on the achievement of certain common and unique objectives described below. These non-financial objectives are important to our success and are designed to enhance stockholder value over the long term.
The Committee met in February 2020 to consider the 2019 performance of each NEO as compared to the individual’s performance goals. Mr. Griess summarized the 2019 performance of the other NEOs and presented information to the Committee for consideration. After evaluating each NEO’s performance, the Committee assigned each NEO an individual performance percentage of 100% for 2019.
Final 2019 Bonus Calculation. The following table shows the calculation of the annual performance bonus earned by each NEO for 2019:
NEO
|
|
Base Salary
|
|
|
x
|
|
NEO
Target Bonus Percentage
|
|
|
x
|
|
Company
Performance Percentage
Achieved
|
|
|
x
|
|
NEO
Performance Percentage
Achieved
|
|
|
=
|
|
2019 Total
Bonus Earned
|
|
Bret C. Griess
|
|
$
|
700,000
|
|
|
|
|
150%
|
|
|
|
|
145.7%
|
|
|
|
|
100%
|
|
|
|
|
$
|
1,529,850
|
|
Rolland B. Johns
|
|
$
|
400,000
|
|
|
|
|
75%
|
|
|
|
|
145.7%
|
|
|
|
|
100%
|
|
|
|
|
$
|
437,100
|
|
Kenneth M. Kennedy
|
|
$
|
420,000
|
|
|
|
|
100%
|
|
|
|
|
145.7%
|
|
|
|
|
100%
|
|
|
|
|
$
|
611,940
|
|
Brian A. Shepherd
|
|
$
|
455,000
|
|
|
|
|
100%
|
|
|
|
|
145.7%
|
|
|
|
|
100%
|
|
|
|
|
$
|
662,935
|
|
Long-Term Incentive Awards
We use our LTI program to provide variable pay compensation in the form of equity that rewards executives when we achieve long-term results that align with stockholders’ interests.
Under our LTI program, we generally grant our NEOs two types of awards, which are administered under our Amended and Restated 2005 Stock Incentive Plan: performance- and time-based restricted stock awards. Based on a review of market data and recommendations from our independent compensation consultant, each NEO is awarded an aggregate LTI value, which is allocated among the two types of awards. For 2019, we continued with our 2018 mix of awards (see table below) to provide the appropriate balance of performance- and time-based compensation to support our long-term strategy. This mix of awards is designed to tie executive compensation to balance performance focus with retention value, and mitigate the risk of over-focus on a single measure.
2019 LTI Award Mix
|
Award Type
|
|
Allocation Percentage
|
|
Alignment to Stockholder Interests
|
Performance-Based Restricted Stock
|
|
60%
|
|
Vesting depends on our performance at the end of a two-year performance period if specified predetermined performance measures are achieved
|
Time-Based Restricted Stock
|
|
40%
|
|
Value realized for the award depends on our stock price when the award vests
|
|
See the Executive Compensation Tables – 2019 Grants of Plan-Based Awards for additional information on the 2019 grants.
The key components of our LTI program are summarized below:
2019 Performance-Based LTI Award. The Committee continued to align LTI compensation for our NEOs with our pay-for-performance philosophy and strategic goals. Similar to last year, the 2019 performance-based awards have an opportunity to vest at the end of a two-year performance period upon the achievement of predetermined objective and quantifiable performance measures.
The program is structured to align both near-term progress and a long-term focus by establishing an opportunity at the end of a two-year cycle to vest the award based on actual performance.
For 2019, the Committee selected financial and operational measures for the program to incentivize and reward long-term strategic progress towards enhancing the success of the business. The following performance-based measures and weighting of such measures were selected by the Committee to align our executive compensation to the creation of long-term stockholder value, company financial performance, strategic growth, and operational excellence.
30 | 2020 Proxy Statement
|
|
|
|
2019 Performance-Based LTI Award
Two-Year Performance Period Ending December 31, 2020
|
Performance Measures
|
|
Weighting
|
|
Definition
|
|
Fully Diluted, Non-GAAP EPS
|
|
60%
|
|
Calculated by dividing Non-GAAP Net Income by the weighted average of diluted shares outstanding for the period. Non-GAAP Net Income is defined as pre-tax income calculated in accordance with GAAP, adding back the following items, as applicable: (a) restructuring and reorganization charges; (b) acquisition-related expenses (e.g. amortization of acquired intangible assets, earn-out compensation and transaction-related costs); (c) stock-based compensation; (d) amortization of original issue discount; and (e) gain (loss) on the extinguishment of debt, less income tax expense, determined by applying an estimated effective income tax rate.
|
|
Ascendon Total Contract Value (“TCV”)
|
|
24%
|
|
Net new TCV during for the two-fiscal-year period ending December 31, 2020 for our Ascendon platform.
|
|
Impact Minutes Improvement
|
|
16%
|
|
Impact Minutes is a key internal operational measure linked to customer satisfaction, with the performance target representing our improvement during the performance period.
|
|
|
At the end of the two-year performance period, our NEOs may earn from 0% to 200% of the target number of performance-based shares based on the level of achievement for each performance measure. At maximum performance, these awards vest at 200% of the target value for each performance measure. At threshold performance these awards vest at 50% of target value, and no awards are vested if performance falls below the established threshold for such measure. No dividends or dividend equivalents are paid on unvested performance-based restricted stock; dividends accrue and accrued dividends are only paid upon vesting.
2019 Time-Based LTI Award. Our time-based restricted stock awards are designed to significantly strengthen the retention value of our LTI program by providing a full value component to balance our performance-based awards. The time-based restricted stock vests ratably over a four-year period, subject to continued employment with our company. No dividends or dividend equivalents are paid on unvested time-based restricted stock; dividends accrue and accrued dividends are only paid upon vesting.
2018 Performance-Based LTI Award Results. The following table summarizes key terms of the NEOs’ 2018 performance-based LTI awards and the 2019 actual performance results for the shares eligible to vest for 2019. In aggregate, 116.5% of the target shares for this grant vested based on the achievement levels below for our financial and operational results as certified by the Committee.
2018 Performance-Based LTI Award
Two-Year Performance Period Ended December 31, 2019
|
Performance Measures
|
|
Weighting
|
|
Performance
Achieved (4)
|
|
Weighted Achievement
|
Organic Revenue (1)
|
|
60%
|
|
115.5%
|
|
69.3%
|
Ascendon Revenue (2)
|
|
24%
|
|
63.4%
|
|
15.2%
|
Impact Minutes Improvement (3)
|
|
16%
|
|
200%
|
|
32.0%
|
Total Weighted Achievement
|
116.5%
|
|
|
|
|
(1)
|
|
Organic Revenue is defined as total 2019 GAAP revenue excluding certain revenues resulting from acquisition-related activities.
|
(2)
|
|
Ascendon Revenue is defined as 2019 Ascendon platform revenues.
|
(3)
|
|
Impact Minutes is a key internal operational measure linked to customer satisfaction, with the performance target representing our improvement during the performance period.
|
(4)
|
|
Performance achieved capped at 200%.
|
|
|
|
|
|
2020 Proxy Statement | 31
|
2017 Performance-Based LTI Award Results. The following table summarizes key terms of the NEOs’ 2017 performance-based LTI awards and the 2019 actual financial results compared to the financial targets for the shares eligible to vest for 2019. Based on the achievement levels below for our 2019 financial results as certified by the Committee, 100% of the third and last tranche of this award vested.
|
2017 Performance-Based LTI Award – Restricted Stock
Three-Year Performance Period Ended December 31, 2019
|
Financial Performance Measures (in millions, except per share amounts)
|
|
|
Revenues
|
|
|
Adjusted EPS (1)
|
2019 Actual (2)
|
|
|
$
|
982.0
|
|
|
$
|
4.34
|
|
Target
|
|
|
$
|
865.0
|
|
|
$
|
2.76
|
|
Minimum Threshold
|
|
|
$
|
849.4
|
|
|
$
|
2.74
|
|
|
|
|
|
|
(1)
|
|
Calculated by dividing Adjusted Net Income by the weighted average of diluted shares outstanding for the period. Adjusted Net Income is defined as pre-tax income calculated in accordance with GAAP, adding back the following items, as applicable: (a) depreciation expense; (b) amortization of original issue discount; (c) acquisition-related costs (e.g. amortization of acquired intangible assets, earn-out compensation and transaction-related costs); (d) amortization of other intangible assets; (e) restructuring and reorganization charges; (f) the difference between the book gain and the cash/economic gain on the retirement of debt; and (g) extraordinary gain or loss on the issuance or retirement of debt obligations, less income tax expense, determined by applying an estimated effective income tax rate.
|
(2)
|
|
The 2019 actual amounts are derived from the audited financial information of the Company as provided in our 2019 Form 10-K. These results and the determination of the earned vesting level are certified by the Committee.
|
|
|
|
32 | 2020 Proxy Statement
|
|
|
Other Considerations
Other Benefits and Employment Agreements
The Committee does not believe that perquisites and other benefits should play a major role in the overall compensation program of our NEOs. We offer our NEOs substantially the same benefits as our other employees, including the opportunity to defer a portion of their annual base salary and annual performance bonus through a 401(k) plan that is generally available Company-wide, and through a more restricted (i.e., participation is limited to vice presidents and above) non-qualified deferred compensation program as discussed later in the 2019 Non-Qualified Deferred Compensation section. Both of these plans include Company matching contributions. The Committee views these deferral programs as individual retirement planning options and not as long-term compensation. The amount of our contributions for each NEO is reported in a footnote to the 2019 Summary Compensation Table in the Executive Compensation Tables that follow. Our NEOs also have employment agreements with the Company. See Employment Agreements section for additional information.
Tax Deductibility of Executive Compensation
Section 162(m) of the Code generally limits to $1 million the amount of compensation we can deduct in any one year for compensation paid to our CEO, CFO, and certain other covered employees. Prior to 2018, the $1 million limit generally did not apply to compensation that was performance-based and provided under a stockholder-approved plan. The Tax Cut and Jobs Act enacted in December 2017 generally eliminated the performance-based exception from Section 162(m) for tax years beginning after 2017, unless the compensation qualifies for transition relief applicable to contracts in place on November 2, 2017. The Committee intends to continue to assess the impact of Section 162(m) on the Company’s compensation programs, including the potential availability of transition relief for awards granted before 2018. While the Committee considers the deductibility of compensation as one factor in determining executive compensation, the Committee also looks at other factors in making its decisions and retains the flexibility to grant discretionary awards and make payments that it determines to be consistent with our goals for our executive compensation program even if the amounts are not deductible by the Company for tax purposes.
Accounting Considerations
ASC Topic 718, Compensation—Stock Compensation (referred to as ASC Topic 718), requires us to recognize an expense for the fair value of equity-based compensation awards over the expected service period. Grants of stock options, restricted stock, and performance restricted stock under our equity incentive award plans will be accounted for under ASC Topic 718. We will consider the accounting implications of significant compensation decisions, especially in connection with decisions that relate to our equity incentive award plans and programs. As accounting standards change, we may revise certain programs to appropriately align accounting expenses of our equity awards with our overall executive compensation philosophy and objectives.
|
|
2020 Proxy Statement | 33
|
REPORT OF THE COMPENSATION COMMITTEE
We have reviewed and discussed with management of the Company the Compensation Discussion and Analysis, which appears in this Proxy Statement as is required by Item 402(b) of SEC Regulation S-K.
Based upon such review and discussions, we recommended to the Board that the Compensation Discussion and Analysis be included in this Proxy Statement.
Compensation Committee of the Board of Directors:
Ronald H. Cooper, Chair
Frank V. Sica
Donald V. Smith
Haiyan Song
James A. Unruh
34 | 2020 Proxy Statement
|
|
|
EXECUTIVE COMPENSATION TABLES
2019 Summary Compensation Table
The following table sets forth certain information with respect to the compensation earned by our NEOs during the years ended December 31, 2019, 2018, and 2017, as applicable. All dollar values have been rounded to the nearest dollar.
Name and Principal Position
|
|
Year
|
|
Salary
|
|
|
Bonus
|
|
|
Stock
Awards (1)
|
|
|
Non-Equity
Incentive Plan
Compensation (2)
|
|
|
All Other
Compensation (4)
|
|
|
Total
|
|
Bret C. Griess
|
|
2019
|
|
$
|
700,000
|
|
|
$
|
-
|
|
|
$
|
3,500,013
|
|
|
$
|
1,529,850
|
|
|
$
|
336,210
|
|
|
$
|
6,066,073
|
|
President and CEO
|
|
2018
|
|
$
|
700,000
|
|
|
$
|
-
|
|
|
$
|
4,699,977
|
|
|
$
|
888,300
|
|
|
$
|
248,105
|
|
|
$
|
6,536,382
|
|
|
|
2017
|
|
$
|
675,000
|
|
|
$
|
104,288
|
|
|
$
|
3,000,018
|
|
|
$
|
1,042,875
|
|
|
$
|
234,622
|
|
|
$
|
5,056,803
|
|
Rolland B. Johns (3)
|
|
2019
|
|
$
|
400,000
|
|
|
$
|
-
|
|
|
$
|
874,973
|
|
|
$
|
437,100
|
|
|
$
|
60,346
|
|
|
$
|
1,772,419
|
|
EVP and CFO
|
|
2018
|
|
$
|
378,119
|
|
|
$
|
-
|
|
|
$
|
752,985
|
|
|
$
|
253,800
|
|
|
$
|
36,323
|
|
|
$
|
1,421,227
|
|
Kenneth M. Kennedy
|
|
2019
|
|
$
|
420,000
|
|
|
$
|
-
|
|
|
$
|
924,970
|
|
|
$
|
611,940
|
|
|
$
|
115,637
|
|
|
$
|
2,072,547
|
|
EVP and President,
|
|
2018
|
|
$
|
420,000
|
|
|
$
|
-
|
|
|
$
|
1,479,991
|
|
|
$
|
355,320
|
|
|
$
|
87,779
|
|
|
$
|
2,343,090
|
|
Technology and Product
|
|
2017
|
|
$
|
381,100
|
|
|
$
|
-
|
|
|
$
|
924,984
|
|
|
$
|
392,533
|
|
|
$
|
63,639
|
|
|
$
|
1,762,256
|
|
Brian A. Shepherd
|
|
2019
|
|
$
|
455,000
|
|
|
$
|
-
|
|
|
$
|
950,030
|
|
|
$
|
662,935
|
|
|
$
|
127,780
|
|
|
$
|
2,195,745
|
|
EVP and Group President
|
|
2018
|
|
$
|
455,000
|
|
|
$
|
-
|
|
|
$
|
1,520,007
|
|
|
$
|
384,930
|
|
|
$
|
78,915
|
|
|
$
|
2,438,852
|
|
|
|
2017
|
|
$
|
412,000
|
|
|
$
|
42,436
|
|
|
$
|
949,983
|
|
|
$
|
424,360
|
|
|
$
|
60,872
|
|
|
$
|
1,889,651
|
|
|
(1)
|
|
The amounts in the Stock Awards column reflect the aggregate grant date fair value of performance- and time-based restricted stock awards granted in each respective year, computed in accordance with FASB ASC Topic 718, excluding the impact of estimated forfeitures. Assumptions used to determine these amounts are set forth in Note 13 of our 2019 Form 10-K. The aggregate grant date fair value is calculated using the closing price of our common stock on the date of grant and the target number of performance-based shares that can be earned under the awards. For 2019, the total aggregate grant date fair value of restricted stock awards, assuming the highest level of performance, would be as follows: Mr. Griess - $5,600,021, Mr. Johns - $1,399,965, Mr. Kennedy - $1,479,960, and Mr. Shepherd - $1,520,040. See 2019 Grants of Plan-Based Awards for details.
|
(2)
|
|
Represents the annual performance bonus amounts earned by our NEOs in the respective years. Such amounts are paid during the first quarter following the year in which the bonus was earned. Details of the amounts in the “Non-Equity Incentive Plan Compensation” column are reflected in the Final 2019 Bonus Calculation.
|
(3)
|
|
Mr. Johns was promoted to EVP and CFO effective May 17, 2018. Correspondingly, the Board approved a salary increase to $400,000 resulting in a total annualized salary of $378,119.
|
(4)
|
|
For 2019, details of the “All Other Compensation” column are as follows:
|
|
|
|
|
|
All Other Compensation Items
|
|
Bret C.
Griess
|
|
|
Rolland B.
Johns
|
|
|
Kenneth M.
Kennedy
|
|
|
Brian A.
Shepherd
|
|
|
|
Company 401(k) retirement plan contributions
|
|
$
|
11,200
|
|
|
$
|
11,200
|
|
|
$
|
13,393
|
|
|
$
|
14,403
|
|
|
|
Accrued dividends (a)
|
|
|
318,622
|
|
|
|
49,008
|
|
|
|
95,856
|
|
|
|
103,459
|
|
|
|
Company non-qualified deferred compensation contributions
|
|
|
6,250
|
|
|
|
-
|
|
|
|
6,250
|
|
|
|
5,688
|
|
|
|
Perquisites or other benefits (b)
|
|
|
138
|
|
|
|
138
|
|
|
|
138
|
|
|
|
4,230
|
|
|
|
Total All Other Compensation Items
|
|
$
|
336,210
|
|
|
$
|
60,346
|
|
|
$
|
115,637
|
|
|
$
|
127,780
|
|
|
|
|
|
|
|
|
(a)
|
|
Represents accrued dividends on shares of unvested restricted stock where dividends were not factored into the grant date fair value. Our restricted stock award agreements provide for the accrual of dividends for unvested shares of restricted stock. The accrued dividends are subject to the same vesting schedule as the underlying shares and are forfeited if the underlying shares are forfeited.
|
|
|
(b)
|
|
Includes amount of imputed income for group term life insurance and required imputed income for travel cost associated with the employee recognition Award of Excellence trip.
|
|
|
|
|
|
|
|
2020 Proxy Statement | 35
|
2019 Grants of Plan-Based Awards
The following table contains information about grants of non-equity and equity incentive plan-based awards by the Company during 2019 to our NEOs. These amounts are not realized income. All dollar values have been rounded to the nearest dollar.
|
|
|
|
Estimated Possible Payouts
Under Non-Equity Incentive
Plan Awards (1)
|
|
|
Estimated Possible Payouts
Under Equity Incentive
Plan Awards (2)
|
|
|
All Other
Stock
Awards
|
|
|
Grant
Date
|
|
NEO
|
|
Grant Date
|
|
Target
|
|
|
Maximum
|
|
|
Target
(shares)
|
|
|
Maximum
(shares)
|
|
|
Number of
Shares of
Stock (3)
|
|
|
Fair Value of
Stock
Awards
|
|
Bret C. Griess
|
|
|
|
$
|
1,050,000
|
|
|
$
|
2,100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 10, 2019
|
|
|
|
|
|
|
|
|
|
|
51,033
|
|
|
|
102,066
|
|
|
|
|
|
|
$
|
2,100,008
|
|
|
|
March 10, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,022
|
|
|
$
|
1,400,005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rolland B. Johns
|
|
|
|
$
|
300,000
|
|
|
$
|
600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 10, 2019
|
|
|
|
|
|
|
|
|
|
|
12,758
|
|
|
|
25,516
|
|
|
|
|
|
|
$
|
524,992
|
|
|
|
March 10, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,505
|
|
|
$
|
349,981
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kenneth M. Kennedy
|
|
|
|
$
|
420,000
|
|
|
$
|
840,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 10, 2019
|
|
|
|
|
|
|
|
|
|
|
13,487
|
|
|
|
26,974
|
|
|
|
|
|
|
$
|
554,990
|
|
|
|
March 10, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,991
|
|
|
$
|
369,980
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brian A. Shepherd
|
|
|
|
$
|
455,000
|
|
|
$
|
910,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 10, 2019
|
|
|
|
|
|
|
|
|
|
|
13,852
|
|
|
|
27,704
|
|
|
|
|
|
|
$
|
570,010
|
|
|
|
March 10, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,235
|
|
|
$
|
380,020
|
|
|
|
|
(1)
|
|
The amounts represent the potential payouts under our 2019 Annual Performance Bonus Program. The actual amounts earned for 2019 are reported in the 2019 Summary Compensation Table in the column titled “Non-Equity Incentive Plan Compensation." The target award amounts above assume the company performance percentage achieved is 100% and that the NEOs achieve 100% of their personal performance objectives. See the 2019 Annual Performance Bonus for additional information.
|
(2)
|
|
Represents the performance-based restricted stock awards granted in 2019. See 2019 Long-Term Incentive Awards for additional information regarding our performance-based restricted stock awards.
|
(3)
|
|
Represents the time-based restricted stock awards granted in 2019. See 2019 Long-Term Incentive Awards for additional information regarding our time-based restricted stock awards. These restricted stock awards vest in four equal annual installments commencing on the first anniversary of the grant date.
|
|
|
|
36 | 2020 Proxy Statement
|
|
|
Outstanding Equity Awards at December 31, 2019
The following table contains information about all unvested restricted stock awards held at December 31, 2019, by our NEOs. All dollar values have been rounded to the nearest dollar.
|
|
Stock Awards
|
|
NEO
|
|
Number of Shares
of Stock That
Have Not Vested (2)
|
|
|
Market Value of
Shares of Stock
That Have
Not Vested (1)
|
|
|
Equity Incentive
Plan Awards:
Number of
Unearned Shares That
Have Not Vested (3)
|
|
|
Equity Incentive
Plan Awards:
Market or Payout Value of
Unearned Shares That
Have Not Vested (1)
|
|
Bret C. Griess
|
|
|
82,924
|
|
|
$
|
4,293,805
|
|
|
|
234,663
|
|
|
$
|
12,150,850
|
|
Rolland B. Johns
|
|
|
18,173
|
|
|
$
|
940,998
|
|
|
|
43,412
|
|
|
$
|
2,247,873
|
|
Kenneth M. Kennedy
|
|
|
24,246
|
|
|
$
|
1,255,458
|
|
|
|
68,630
|
|
|
$
|
3,553,661
|
|
Brian A. Shepherd
|
|
|
26,439
|
|
|
$
|
1,369,011
|
|
|
|
70,486
|
|
|
$
|
3,649,765
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
The market value was computed by multiplying the number of shares of restricted stock that have not vested as of December 31, 2019, by the closing price of the Company's common stock on December 31, 2019, the last trading day of the year, of $51.78 per share.
|
|
|
|
|
Footnotes continued next page
|
|
|
2020 Proxy Statement | 37
|
|
|
|
|
(2)
|
|
Detailed information relating to the time-based restricted stock awards not vested as of December 31, 2019, is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NEO
|
|
Grant Date
|
|
Shares That
Have Not Vested
|
|
Vesting Dates
|
|
Shares
Vesting
|
|
|
|
Bret C. Griess
|
|
February 25, 2016
|
|
|
4,465
|
|
February 25, 2020
|
|
|
4,465
|
|
|
|
|
|
February 23, 2017
|
|
|
15,049
|
|
February 23, 2020
|
|
|
7,524
|
|
|
|
|
|
|
|
|
|
|
February 23, 2021
|
|
|
7,525
|
|
|
|
|
|
February 22, 2018
|
|
|
29,388
|
|
February 22, 2020
|
|
|
9,796
|
|
|
|
|
|
|
|
|
|
|
February 22, 2021
|
|
|
9,796
|
|
|
|
|
|
|
|
|
|
|
February 22, 2022
|
|
|
9,796
|
|
|
|
|
|
March 10, 2019
|
|
|
34,022
|
|
March 10, 2020
|
|
|
8,505
|
|
|
|
|
|
|
|
|
|
|
March 10, 2021
|
|
|
8,506
|
|
|
|
|
|
|
|
|
|
|
March 10, 2022
|
|
|
8,505
|
|
|
|
|
|
|
|
|
|
|
March 10, 2023
|
|
|
8,506
|
|
|
|
Total
|
|
|
|
|
82,924
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rolland B. Johns
|
|
February 24, 2016
|
|
|
1,387
|
|
February 24, 2020
|
|
|
1,387
|
|
|
|
|
|
February 22, 2017
|
|
|
1,764
|
|
February 22, 2020
|
|
|
882
|
|
|
|
|
|
|
|
|
|
|
February 22, 2021
|
|
|
882
|
|
|
|
|
|
March 10, 2018
|
|
|
2,043
|
|
March 10, 2020
|
|
|
681
|
|
|
|
|
|
|
|
|
|
|
March 10, 2021
|
|
|
681
|
|
|
|
|
|
|
|
|
|
|
March 10, 2022
|
|
|
681
|
|
|
|
|
|
June 10, 2018
|
|
|
4,474
|
|
June 10, 2020
|
|
|
1,491
|
|
|
|
|
|
|
|
|
|
|
June 10, 2021
|
|
|
1,491
|
|
|
|
|
|
|
|
|
|
|
June 10, 2022
|
|
|
1,492
|
|
|
|
|
|
March 10, 2019
|
|
|
8,505
|
|
March 10, 2020
|
|
|
2,126
|
|
|
|
|
|
|
|
|
|
|
March 10, 2021
|
|
|
2,126
|
|
|
|
|
|
|
|
|
|
|
March 10, 2022
|
|
|
2,126
|
|
|
|
|
|
|
|
|
|
|
March 10, 2023
|
|
|
2,127
|
|
|
|
Total
|
|
|
|
|
18,173
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kenneth M. Kennedy
|
|
February 25, 2016
|
|
|
1,361
|
|
February 25, 2020
|
|
|
1,361
|
|
|
|
|
|
February 23, 2017
|
|
|
4,640
|
|
February 23, 2020
|
|
|
2,320
|
|
|
|
|
|
|
|
|
|
|
February 23, 2021
|
|
|
2,320
|
|
|
|
|
|
February 22, 2018
|
|
|
9,254
|
|
February 22, 2020
|
|
|
3,085
|
|
|
|
|
|
|
|
|
|
|
February 22, 2021
|
|
|
3,084
|
|
|
|
|
|
|
|
|
|
|
February 22, 2022
|
|
|
3,085
|
|
|
|
|
|
March 10, 2019
|
|
|
8,991
|
|
March 10, 2020
|
|
|
2,247
|
|
|
|
|
|
|
|
|
|
|
March 10, 2021
|
|
|
2,248
|
|
|
|
|
|
|
|
|
|
|
March 10, 2022
|
|
|
2,248
|
|
|
|
|
|
|
|
|
|
|
March 10, 2023
|
|
|
2,248
|
|
|
|
Total
|
|
|
|
|
24,246
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brian A. Shepherd
|
|
February 25, 2016
|
|
|
2,934
|
|
February 25, 2020
|
|
|
2,934
|
|
|
|
|
|
February 23, 2017
|
|
|
4,766
|
|
February 23, 2020
|
|
|
2,383
|
|
|
|
|
|
|
|
|
|
|
February 23, 2021
|
|
|
2,383
|
|
|
|
|
|
February 22, 2018
|
|
|
9,504
|
|
February 22, 2020
|
|
|
3,168
|
|
|
|
|
|
|
|
|
|
|
February 22, 2021
|
|
|
3,168
|
|
|
|
|
|
|
|
|
|
|
February 22, 2022
|
|
|
3,168
|
|
|
|
|
|
March 10, 2019
|
|
|
9,235
|
|
March 10, 2020
|
|
|
2,308
|
|
|
|
|
|
|
|
|
|
|
March 10, 2021
|
|
|
2,309
|
|
|
|
|
|
|
|
|
|
|
March 10, 2022
|
|
|
2,309
|
|
|
|
|
|
|
|
|
|
|
March 10, 2023
|
|
|
2,309
|
|
|
|
Total
|
|
|
|
|
26,439
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Footnotes continued next page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38 | 2020 Proxy Statement
|
|
|
|
(3)
|
|
Represents performance-based restricted stock awards that vest if certain predetermined performance goals are achieved at the end of the applicable two- or three-year performance period and when the Compensation Committee certifies the results in February or March of the applicable year. See 2019 Compensation—Long Term Incentive Awards for more information regarding the performance-based restricted stock awards. The amounts reported in the table above are based on the achievement of maximum performance in future performance periods. Detailed information for the target and maximum number of performance-based restricted stock awards shares not vested as of December 31, 2019, is as follows:
|
|
|
|
|
|
|
|
Shares That
Have Not Vested
|
|
|
|
NEO
|
|
Grant Date
|
|
Target
|
|
Maximum
|
|
|
|
Bret C. Griess
|
|
February 23, 2017
|
|
|
15,049
|
|
|
15,049
|
|
|
|
|
|
February 22, 2018
|
|
|
58,774
|
|
|
117,548
|
|
|
|
|
|
March 10, 2019
|
|
|
51,033
|
|
|
102,066
|
|
|
|
Total
|
|
|
|
|
124,856
|
|
|
234,663
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rolland B. Johns
|
|
June 10, 2018
|
|
|
8,948
|
|
|
17,896
|
|
|
|
|
|
March 10, 2019
|
|
|
12,758
|
|
|
25,516
|
|
|
|
Total
|
|
|
|
|
21,706
|
|
|
43,412
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kenneth M. Kennedy
|
|
February 23, 2017
|
|
|
4,640
|
|
|
4,640
|
|
|
|
|
|
February 22, 2018
|
|
|
18,508
|
|
|
37,016
|
|
|
|
|
|
March 10, 2019
|
|
|
13,487
|
|
|
26,974
|
|
|
|
Total
|
|
|
|
|
36,635
|
|
|
68,630
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brian A. Shepherd
|
|
February 23, 2017
|
|
|
4,766
|
|
|
4,766
|
|
|
|
|
|
February 22, 2018
|
|
|
19,008
|
|
|
38,016
|
|
|
|
|
|
March 10, 2019
|
|
|
13,852
|
|
|
27,704
|
|
|
|
Total
|
|
|
|
|
37,626
|
|
|
70,486
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2020 Proxy Statement | 39
|
2019 Stock Vested
The following table contains information concerning shares of restricted stock that vested for our NEOs during 2019. All dollar values have been rounded to the nearest dollar.
|
|
Stock Awards
|
|
NEO
|
|
Number of Shares
Acquired on Vesting (1)
|
|
|
Value Realized
on Vesting (2)
|
|
Bret C. Griess
|
|
|
48,400
|
|
|
$
|
2,132,196
|
|
Rolland B. Johns
|
|
|
6,077
|
|
|
$
|
262,223
|
|
Kenneth M. Kennedy
|
|
|
12,946
|
|
|
$
|
539,397
|
|
Brian A. Shepherd
|
|
|
13,250
|
|
|
$
|
552,319
|
|
(1)
|
|
This column includes both performance- and time-based shares of restricted stock that vested in 2019.
|
(2)
|
|
This column reflects the total dollar value realized by the NEO upon the vesting of restricted stock in 2019. This amount was determined based on the closing market price of the Company’s common stock on the respective vesting dates.
|
|
40 | 2020 Proxy Statement
|
|
|
2019 Non-Qualified Deferred Compensation
The following table contains information about contributions, earnings, withdrawals, and account balances for our NEOs under the Company’s non-qualified Wealth Accumulation Plan. All amounts have been rounded to the nearest dollar.
The Wealth Accumulation Plan is an elective, unfunded deferred compensation plan intended to build net worth through the deferral of cash compensation on a before-tax basis. Participation in the Wealth Accumulation Plan is limited to vice presidents and above, including the NEOs. Each participant must have elected by December of the preceding year to defer: (1) up to 25% of the participant’s base salary and/or (2) up to 100% of the participant’s cash bonus. The NEOs may elect to defer up to $700,000 in the aggregate for any one year. We make a matching contribution equal to 25% of the deferral, up to a maximum of $6,250 per participant for any one plan year. The aggregate amount each NEO elected to defer and the amount that the Company contributed to the Wealth Accumulation Plan is shown in the Non-Qualified Deferred Compensation Table below.
Payment elections for the deferral year must be made by December of the preceding year. Participants can elect to receive payment either as an in-service distribution or upon termination of employment.
Payment can be made as a lump sum or in monthly installments for up to 180 months, depending on whether the participant elected to receive payment as an in-service distribution or upon termination of employment, and the payment options offered at the time of the participant’s deferral election. Generally, Wealth Accumulation Plan deferral account benefit payments will not begin earlier than the elected commencement date. In the event of a participant’s death, the participant’s deferred compensation benefit will be paid to the participant’s beneficiaries and/or estate in a lump sum. Participants may request an early withdrawal in the event of an unforeseen emergency, which request is subject to approval. For all participants, distributions triggered by termination of employment are automatically delayed six months. The Company has the right to terminate the Wealth Accumulation Plan and distribute all vested amounts credited to participant accounts upon a change of control.
Participants are always vested in their own salary deferrals and vest 100% in Company matching contributions after three years of service. All of the NEOs who participated in the plan are now fully vested in their Wealth Accumulation Plan account balances.
NEO
|
|
Aggregate
Balance at
December 31, 2018
|
|
|
Executive
Contributions
in 2019 (1)
|
|
|
Company Matching
Contributions
in 2019 (2)
|
|
|
Aggregate
Earnings
in 2019
|
|
|
Aggregate
Withdrawals/
Distributions
in 2019
|
|
|
Aggregate
Balance at
December 31, 2019 (3)
|
|
Bret C. Griess
|
|
$
|
1,747,496
|
|
|
$
|
124,910
|
|
|
$
|
6,250
|
|
|
$
|
496,080
|
|
|
$
|
-
|
|
|
$
|
2,374,736
|
|
Rolland B. Johns
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
Kenneth M. Kennedy
|
|
$
|
912,088
|
|
|
$
|
24,231
|
|
|
$
|
6,057
|
|
|
$
|
245,354
|
|
|
$
|
-
|
|
|
$
|
1,187,730
|
|
Brian A. Shepherd
|
|
$
|
96,428
|
|
|
$
|
21,875
|
|
|
$
|
5,469
|
|
|
$
|
20,268
|
|
|
$
|
-
|
|
|
$
|
144,040
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
These amounts are also included in the "Salary" or "Non-Equity Incentive Plan Compensation" columns in the 2019 Summary Compensation Table.
|
(2)
|
|
These amounts were reported as "All Other Compensation" in the 2019 Summary Compensation Table and as "Company non-qualified deferred compensation contributions."
|
(3)
|
|
The aggregate balance includes the following executive and Company contribution amounts reported in the summary compensation tables in prior year proxy statements beginning with the 2007 proxy statement: Mr. Griess - $705,712, Mr. Kennedy - $111,534, and Mr. Shepherd - $100,989.
|
|
|
|
|
|
2020 Proxy Statement | 41
|
Employment Agreements
Employment Agreements with Mr. Griess, Mr. Johns, Mr. Kennedy, and Mr. Shepherd
General Terms
We entered into employment agreements with each of Mr. Griess, Mr. Johns, Mr. Kennedy, and Mr. Shepherd, which are all substantially similar, except as noted below.
Each agreement continues in effect until the NEO’s termination of employment. Each agreement provides for a base salary at an annual rate not less than the rate for the preceding calendar year. In addition, the employment agreements set the NEO’s annual incentive bonus opportunity at not less than: 150% of base salary for Mr. Griess, 100% of base salary for Mr. Kennedy and Mr. Shepherd, and 75% of base salary for Mr. Johns. The employment agreements include reimbursement of business expenses, vacations and holidays, and other customary benefits. In addition, the employment agreements contain customary confidentiality provisions, non-solicitation, and non-competition provisions for one year following the termination of employment.
Termination and Change of Control Provisions
Each employment agreement also contains certain benefits upon the NEO’s termination of employment or Change of Control of the Company, as outlined below.
If the NEO’s employment is terminated due to death or disability, he (or his estate) would receive his: (1) accrued and unpaid base salary and earned and unused vacation pay through the employment termination date in a lump sum payment (the “accrued benefits”); (2) any other amounts or benefits earned, accrued, or owed to him but not paid as of the employment termination date; (3) a pro rata portion of his annual incentive bonus for the year in which his employment terminates, payable at the same time as payments to continuing NEOs; and (4) in the event of disability, continued participation at the Company’s expense in group medical, dental, life, and long-term disability benefits (“group insurance benefits”) until age 65, unless restricted or prohibited.
If the NEO’s employment is terminated for Cause, he would receive only his accrued benefits and any other amounts or benefits earned, accrued, or owed to him but not paid through the employment termination date.
If the NEO voluntarily resigns, he would receive only his accrued benefits through the employment termination date and any other amounts or benefits earned, accrued, or owed to him but not paid as of the employment termination date. If his voluntary resignation were effective on December 31 of a particular year, he would receive his annual incentive bonus for that year to be paid in accordance with the regular payment schedule. If prior to the occurrence of a Change of Control, the Company terminates the NEO’s employment for any reason other than Cause, or his death or disability, or he terminates his employment on account of Constructive Termination, then he would receive: (1) his accrued benefits; (2) any other amounts or benefits earned, accrued, or owed to him but not paid through the employment termination date; and (3) if he executes a release of all claims and the revocation period expires within 45 days, and he continues to comply with his fiduciary obligations, the restrictive covenants, and any other material ongoing obligations: (a) an amount equal to 100% of his average W-2 wages for the three prior calendar years payable in accordance with the Company’s normal payroll practices (excluding 2016 for Mr. Shepherd because he was not employed for the full year); and (b) continued participation at the Company’s expense in the group insurance benefits up to one year, unless restricted or prohibited.
If within 18 months after the occurrence of a Change of Control, the Company (or any permitted assignee) terminates the NEO’s employment for any reason other than Cause, or his death or disability, or he terminates his employment on account of a Constructive Termination, then he would receive: (1) his accrued benefits; (2) any other amounts or benefits earned, accrued, or owed to him but not paid through the employment termination date; (3) automatic vesting (subject to limitations) of all unvested restricted stock awards that are in effect on the termination date and which provide for automatic vesting upon his involuntary termination without Cause after a Change of Control; and (4) if he executes a release of all claims and the revocation period expires within 45 days, and he continues to comply with his fiduciary obligations, the restrictive covenants, and any other material ongoing obligations: (a) an amount equal to three (3) times the sum of his base salary for the calendar year in which the termination occurs plus the performance-based cash bonus which he would receive for the calendar year in which the termination occurs if the Company attained 100% of its performance goals for such calendar year, reduced as necessary so that the actual amount, if any, payable plus the
42 | 2020 Proxy Statement
|
|
|
applicable amounts of any other relevant payments or benefits is $1.00 less than the amount which would result in the imposition of a tax under Section 4999 of the Code, on "excess parachute payments" (as defined in Section 280G of the Code); and (b) continued participation at the Company’s expense in the group insurance benefits up to two years, unless restricted or prohibited.
Clawback
A “clawback” provision has been included in each of the employment agreements. In certain cases, the Company is authorized to reduce or cancel, or require the recovery of all or a portion of the NEO’s annual bonus or LTI compensation award if the Board determines that the NEO has engaged in intentional misconduct that has led to a material misstatement of our financial statements.
Definitions
Cause. Under the employment agreements, the Board may terminate the NEO’s employment for Cause. Cause generally includes: (1) the NEO’s confession or conviction of theft, fraud, embezzlement, or other crime involving dishonesty; (2) the NEO’s certification of materially inaccurate financial or other information pertaining to the Company or any of its subsidiaries with actual knowledge of such inaccuracies; (3) the NEO’s refusal or willful failure to cooperate with an investigation by a governmental agency pertaining to the financial or other business affairs of the Company or any of its subsidiaries unless such refusal or willful failure is based upon a written direction of the Board or the written advice of counsel; (4) the NEO’s excessive absenteeism (other than by reason of physical injury, disease, or mental illness) without a reasonable justification and failure on the part of the NEO to cure such absenteeism within 20 days after he receives a written notice from the Board setting forth the particulars of such absenteeism; (5) material violation by the NEO of his nondisclosure obligations under the employment agreement; (6) habitual and material negligence by the NEO in the performance of his duties and responsibilities under the employment agreement and failure on the part of the NEO to cure such negligence within 20 days after he receives a written notice from the Board setting forth in reasonable detail the particulars of such negligence; (7) material non-compliance by the NEO with his performance obligations under the employment agreement and failure to correct such non-compliance within 20 days after his receipt of a written notice from the Board setting forth in reasonable detail the particulars of such non-compliance; (8) material failure by the NEO to comply with a lawful directive of the Board and failure to cure such non-compliance within 20 days after his receipt of a written notice from the Board setting forth in reasonable detail the particulars of such non-compliance; (9) a material breach by the NEO of any of his fiduciary duties to the Company or its subsidiaries and, if such breach is curable, the NEO’s failure to cure such breach within 10 days after he receives a written notice from the Board setting forth in reasonable detail the particulars of such breach; or (10) willful misconduct or fraud on the part of the NEO in the performance of the NEO’s duties under the employment agreement as determined in good faith by the Board.
In no event will the results of operations of the Company or any business judgment made in good faith by the NEO constitute an independent basis for termination for Cause of the NEO’s employment under the employment agreement. Any termination of the NEO’s employment for Cause must be authorized by a majority vote of the Board taken within six months after a majority of the members of the Board (other than the NEO) have actual knowledge of the occurrence of the event or conduct constituting the Cause for such termination.
Change of Control. For purposes of the employment agreements and the unvested restricted stock awards, a “Change of Control” of the Company generally includes: (1) the merger or consolidation of the Company into another corporation; (2) the acquisition of 30% or more of the outstanding voting capital stock of the Company by any person, entity, or group of persons; (3) a “going private” transaction involving the Company; (4) the sale or other disposition of all or substantially all of the Company’s property and assets; (5) the disposition to a third party of a major portion or portions of the Company’s business (measured either by the consideration received as a percentage of the market value of the common stock or by the revenues of the Company represented by the business being sold); or (6) a change in a majority of the members of the Board without approval of 75% of the incumbent directors. The foregoing is merely a summary of the more detailed definition of “Change of Control” that appears in the applicable employment agreements.
|
|
2020 Proxy Statement | 43
|
Constructive Termination. For purposes of the employment agreements, a “Constructive Termination” generally means any action by the Board or CEO or a permitted assignee, without the NEO’s prior consent, that materially and adversely alters the authority, duties, or responsibilities of the NEO. The NEO must provide written notice to the Board or the permitted assignee of the existence of the condition giving rise to the Constructive Termination within 90 days following the date the NEO first becomes aware of the existence of the condition and the Board or permitted assignee must fail to materially cure the condition within 30 days following the notice.
44 | 2020 Proxy Statement
|
|
|
Potential Payments Upon Termination of Employment
The following describes the additional amount of compensation that would be paid to each of our NEOs in the event of a termination of the NEO’s employment under various scenarios. The amounts shown assume that such termination was effective as of December 31, 2019, and include estimates of the amounts that would be paid to each NEO upon such termination. The closing price of our common stock as of December 31, 2019 (the last trading day of our 2019 fiscal year), $51.78 per share, is used in determining the potential value of accelerated vesting of restricted stock awards. The actual amounts to be paid can only be determined at the time of such NEO’s separation from us.
Termination for Death, Disability, or Voluntary Resignation
Assuming termination of employment on December 31, 2019, on account of the death of Mr. Griess, Mr. Johns, Mr. Kennedy, or Mr. Shepherd, or by reason of the NEO’s disability, or his voluntary resignation, the NEO would receive his accrued benefits, any other amounts or benefits earned, accrued, or owed to him but not paid as of the employment termination date, and his incentive bonus for 2019. In addition, if the NEO’s employment is terminated by reason of his disability, the NEO would receive continued coverage under the group insurance benefits until the first to occur of the cessation of such disability or the attainment of age 65. The monthly premiums at December 31, 2019, for the group insurance benefits were approximately $2,256 for Mr. Griess (age 51), $2,037 for Mr. Johns (age 50), $1,922 for Mr. Kennedy (age 50), and $1,819 for Mr. Shepherd (age 52). In February 2019, the Compensation Committee amended the terms of all outstanding equity awards such that all unvested time-based equity awards will vest in full upon the holder’s death. The values of the unvested time-based awards for each of our NEOs as of December 31, 2019, were $4,293,805 for Mr. Griess, $940,998 for Mr. Johns, $1,255,458 for Mr. Kennedy, and $1,369,011 for Mr. Shepherd. For more information, see Outstanding Equity Awards as of December 31, 2019.
Termination for Cause
Assuming termination of employment on December 31, 2019, by the Company for Cause for Mr. Griess, Mr. Johns, Mr. Kennedy, or Mr. Shepherd, the NEO would receive his accrued benefits through the termination date and any other amounts or benefits earned, accrued, or owed to him but not paid as of the employment termination date.
Termination Without Cause Prior to a Change of Control
Assuming termination of employment on December 31, 2019, by the Company without Cause (or a Constructive Termination by the NEO) prior to a Change of Control for Mr. Griess, Mr. Johns, Mr. Kennedy, or Mr. Shepherd, the NEO would receive his accrued benefits through the termination date, and any other amounts or benefits earned, accrued, or owed to him but not paid as of the employment termination date. Subject to an irrevocable release, he would also receive an amount equal to 100% of his average W-2 wages for the three prior calendar years (excluding 2016 for Mr. Shepherd because he was not employed for the full year) and continued coverage under the group insurance benefits as shown in the following table.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination Without Cause Prior to a Change of Control
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment or Benefit
|
|
Bret C.
Griess
|
|
|
Rolland B.
Johns
|
|
|
Kenneth M.
Kennedy
|
|
|
Brian A.
Shepherd
|
|
Cash Amount (1)
|
|
$
|
4,342,475
|
|
|
$
|
867,570
|
|
|
$
|
1,304,887
|
|
|
$
|
1,239,744
|
|
Group medical, dental, life, and long-term disability benefits (2)
|
|
|
27,068
|
|
|
|
24,445
|
|
|
|
23,065
|
|
|
|
21,825
|
|
Totals
|
|
$
|
4,369,543
|
|
|
$
|
892,015
|
|
|
$
|
1,327,952
|
|
|
$
|
1,261,569
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Amount payable in substantially equal installments in accordance with the Company's normal payroll practices for the twelve (12) months following the termination date; provided, that such payments shall commence on the first regularly scheduled payroll date that is at least sixty (60) days following the termination date.
|
(2)
|
|
Amount represents premiums for twelve (12) months, based upon monthly premiums being paid as of December 31, 2019. Benefits will cease if the NEO receives substantially equivalent benefits from another employer.
|
|
|
|
2020 Proxy Statement | 45
|
Termination Without Cause After a Change of Control
Assuming termination of employment on December 31, 2019, by the Company, without Cause (including a Constructive Termination) after a Change of Control, the NEO would receive his accrued benefits; any other amounts or benefits earned, accrued, or owed to him but not paid as of the employment termination date; and vesting of all unvested shares of restricted stock held on December 31, 2019 subject to limitations. Subject to an irrevocable release, he would also receive: (a) an amount equal to three (3) times the sum of his base salary plus the performance-based cash bonus which he would receive if the Company attained 100% of its performance goals, that together with other compensation and benefits, would not exceed the Section 280G excise tax threshold limit; and (b) continued coverage under the group insurance benefits for two (2) years as shown in the following table. The table includes the value of unvested shares of restricted stock based on the following share amounts: Mr. Griess (207,780 shares), Mr. Johns (39,879 shares), Mr. Kennedy (60,881 shares), and Mr. Shepherd (64,065 shares).
Termination Without Cause After a Change of Control
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment or Benefit
|
|
Bret C.
Griess
|
|
|
Rolland B.
Johns
|
|
|
Kenneth M.
Kennedy
|
|
|
Brian A.
Shepherd
|
|
Cash Amount (1)
|
|
$
|
2,923,088
|
|
|
$
|
770,994
|
|
|
$
|
1,094,949
|
|
|
$
|
1,524,899
|
|
Group medical, dental, life, and long-term disability benefits (2)
|
|
|
54,136
|
|
|
|
48,890
|
|
|
|
46,130
|
|
|
|
43,650
|
|
Acceleration of vesting of restricted stock awards (3)
|
|
|
10,758,848
|
|
|
|
2,064,935
|
|
|
|
3,152,418
|
|
|
|
3,317,286
|
|
Totals
|
|
$
|
13,736,072
|
|
|
$
|
2,884,819
|
|
|
$
|
4,293,497
|
|
|
$
|
4,885,835
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Amount would be paid in a lump sum within thirty (30) days after the termination of employment without regard to other employment.
|
(2)
|
|
Amount represents premiums for twenty-four (24) months, based upon monthly premiums being paid as of December 31, 2019. Benefits will cease if the NEO receives substantially equivalent benefits from another employer.
|
(3)
|
|
Amount represents the number of shares of unvested restricted stock that would vest upon the termination of employment after a Change of Control, multiplied by the closing market price of the common stock on December 31, 2019, the last trading day of the year, of $51.78 per share.
|
|
46 | 2020 Proxy Statement
|
|
|
CEO PAY RATIO
Pursuant to Item 402(u) of SEC Regulation S-K, we are required to annually disclose the ratio of the annual total compensation of our CEO to that of our median employee.
We believe the pay ratio disclosed herein is a reasonable estimate calculated in a manner consistent with Item 402(u) of SEC Regulation S-K. To identify the median employee in 2019 and to determine the annual total compensation of our median employee and our CEO, we took the following steps:
|
▪
|
We selected December 31, 2019 as the date on which we would identify our median employee because it enabled us to make such identification in an efficient and reasonable manner;
|
|
▪
|
We identified our median employee, after accumulating annual base pay, bonus earned, and equity granted (“Annual Compensation”) for our entire global employee workforce, excluding our CEO, based on the local currency of the countries in which they were employed for the fiscal year that ended on December 31, 2019;
|
|
▪
|
Each employee’s Annual Compensation was then converted to U.S. Dollars using average foreign currency rates prevailing during the year, and arrayed high to low to identify our median employee; and
|
|
▪
|
Once the median employee was identified using Annual Compensation, we used the same annual compensation elements required for inclusion in our 2019 Summary Compensation Table for our NEOs and calculated the annual total compensation for our median employee to be $71,570 for the year ended December 31, 2019.
|
Our CEO’s annual total compensation for 2019 was $6,066,073, as reported in the 2019 Summary Compensation Table in the Executive Compensation Tables section, and was approximately 85 times the annual total compensation for the median employee.
|
|
|
2020 Proxy Statement | 47
|
|
PROPOSAL 2 – ADVISORY VOTE TO APPROVE the COMPENSATION of our named executive officers
Pursuant to Section 14A of the Exchange Act, we are asking our stockholders to vote to approve, on an advisory (nonbinding) basis, the compensation of our NEOs as disclosed in this proxy statement. This proposal, commonly known as a “say-on-pay” proposal, gives our stockholders the opportunity to express their views on the compensation of our NEOs on an annual basis. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our NEOs and the philosophy, policies, and practices described in this proxy statement.
As described in Compensation Discussion and Analysis, our executive compensation program is designed to attract and retain qualified executives, recognize and reward individual performance, and align executive pay with stockholder return over both the short and long term. Under this program, our NEOs are rewarded for the achievement of specific annual and long-term strategic, financial, and operational goals, and increases in stockholder value. For additional information about our executive compensation program, please read Compensation Discussion and Analysis.
Accordingly, we are asking our stockholders to vote “FOR” the following resolution at our Annual Meeting:
“RESOLVED, that the compensation paid to the Company’s named executive officers, as disclosed pursuant to Item 402 of SEC Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion, is hereby APPROVED.”
The say-on-pay vote is advisory, and therefore not binding on the Company, the Compensation Committee, or our Board. The Board and Compensation Committee value the opinions of our stockholders and will consider the outcome of the vote when considering future decisions on the compensation of our NEOs.
The Board Recommends a Vote FOR the Approval of the Advisory Vote on the Compensation of Our NEOs.
48 | 2020 Proxy Statement
|
|
|
PROPOSAL 3 – approval of amendment and restatement of the csg systems international, inc. amended and restated 2005 stock incentive plan
Our Board, upon the recommendation of the Compensation Committee, is asking stockholders to approve an amendment and restatement of the CSG Systems International, Inc. Amended and Restated 2005 Stock Incentive Plan (the “2005 Plan”) to, among other things, authorize an additional 3,600,000 shares under the plan.
The 2005 Plan was initially approved by the Board and our stockholders in 2005, and our stockholders have periodically re-approved the 2005 Plan, most recently at the 2018 Annual Meeting of Stockholders. The amendment and restatement of the 2005 Plan (the “A&R 2005 Plan”), upon recommendation of the Compensation Committee, was approved by our Board in February 2020, subject to stockholder approval. If approved by our stockholders, the A&R 2005 Plan will become effective as of the date of the Annual Meeting. If our stockholders do not approve the A&R 2005 Plan, the 2005 Plan will remain as previously approved by our stockholders, and will remain available for new grants to the extent shares remain available for issuance under the plan.
BACKGROUND AND AMENDMENTS TO THE PLAN
Our Board, the Compensation Committee, and our management all believe that long-term equity incentive compensation is essential to our continued ability to attract, retain, and motivate the individuals required to successfully execute our business plans, grow and achieve strong results. Recruitment and retention of highly skilled leaders is a key to our future success. Equity incentives are an important component of our compensation philosophy, intended to provide ownership opportunities and performance-based incentives to our directors, executives, and employees to directly align the recipient's interests with those of our stockholders.
The proposed A&R 2005 Plan includes, together with one immaterial change, an amendment to increase the number of shares authorized for issuance under the 2005 Plan by 3,600,000 shares.
Increase in Authorized Shares. The A&R 2005 Plan would increase the number of shares authorized for issuance by 3,600,000 shares, for a total of 25,000,000 shares reserved for issuance. For the purposes of the A&R 2005 Plan, shares covered by an award of a stock bonus, restricted stock, restricted stock units, or performance units are considered as “Full Value” awards, and count against the maximum number of shares which may be issued as two shares for every one share granted or issued in payment of the award (2:1).
As of February 28, 2020, a total of 3,069,710 shares remained available for issuance under the 2005 Plan. The amendment will increase the number of shares available under the 2005 Plan to 6,669,710 or 20.3% of our common stock outstanding as of February 28, 2020. The last reported sale price of our common stock at the close of business on February 28, 2020 on the Nasdaq Global Select Market was $44.25 per share.
We regularly monitor the burn rate of our equity compensation plans. Based on the ISS Burn Rate calculation methodology, our burn rate over the past three years is 4.39%. We believe our burn rate and current equity overhang is reasonable given the size of our Company, comparability to our peers, and the judicious use of equity to finance our Company.
|
|
2020 Proxy Statement | 49
|
Due to the aforementioned considerations, our Board and the Compensation Committee believe the proposed share increase is reasonable and appropriate. At this time, we expect that these shares, in conjunction with the shares currently available for grant under the 2005 Plan, will be sufficient to cover awards as determined appropriate by the Compensation Committee to be granted in the next three to five years; however, this timeframe is an estimate used to determine the requested number of shares of common stock under the 2005 Plan and future circumstances may require change to our equity grant practices. The table below sets forth, as of February 28, 2020, information regarding outstanding awards and shares remaining available for grant under the 2005 Plan, which is our only active plan under which equity-based compensation awards can be granted.
Total Number of Unvested Full Value Awards Outstanding
|
|
|
823,223
|
|
|
Total Number of Stock Options and Stock Appreciation Rights (SARs) Outstanding
|
|
|
-
|
|
|
Weighted Average Exercise Price of Outstanding Stock Options and SARs
|
|
|
-
|
|
|
Weighted Average Remaining Term of Outstanding Stock Options and SARs
|
|
|
-
|
|
|
Number of Remaining Shares Available under the 2005 Plan
|
|
|
3,069,710
|
|
|
Key Features and Corporate Governance. The A&R 2005 Plan includes several features that are consistent with the interests of our stockholders and sound corporate governance practices, including the following:
|
▪
|
Full Value share counting. Full Value awards count against the maximum number of shares which may be issued under the A&R 2005 Plan as two shares for every one share (2:1) granted or issued in payment of the award.
|
|
▪
|
No automatic share replenishment or “evergreen” provision. There is no evergreen feature pursuant to which the shares authorized for issuance under the A&R 2005 Plan can be automatically replenished.
|
|
▪
|
No liberal share counting or “recycling” of shares. Shares withheld by us for payment of the exercise price of an award or to satisfy tax withholding obligations, or repurchased by us with proceeds collected in connection with the exercise of options, are not available again for grant under the A&R 2005 Plan.
|
|
▪
|
No repricing of stock options or SARs without stockholder approval. Stock options and stock appreciation rights (“SARs”) may not be repriced (repricing, exchange, substitution, and cash buyouts) without prior approval by our stockholders.
|
|
▪
|
No discounted options or SARs. Stock options and SARs may not be granted with an exercise or measurement price lower than the fair market value of the underlying shares on the date of grant.
|
SUMMARY OF THE PLAN
The material terms of our A&R 2005 Plan are summarized below. This summary, however, does not purport to be complete and is subject to and qualified in its entirety by the terms of the A&R 2005 Plan, which is attached as Appendix A.
Types of Awards. The A&R 2005 Plan authorizes the grant of incentive stock options, non-qualified stock options, stock appreciation rights, performance unit awards, restricted stock awards, restricted stock unit awards, and stock bonus awards.
Administration. The Board has delegated authority to the Compensation Committee (the “Committee”) to administer the A&R 2005 Plan. The Committee has authority to interpret the A&R 2005 Plan, select the officers, key employees, and non-employee directors to whom awards will be granted, determine type, amount, size, terms and conditions of each award and make certain other determinations. The Committee may establish sub-plans in connection with grants to employees in non-U.S. jurisdictions. The Committee may delegate certain of its authority to officers of the Company.
Eligibility. Officers and other key employees of the Company or any subsidiary and non-employee directors of the Company are eligible to receive awards under the A&R 2005 Plan, when selected for participation by the Committee. As of February 28, 2020, we had ten non-employee directors and approximately 4,500 employees.
Stock Subject to the A&R 2005 Plan. A total of 25,000,000 shares of our common stock may be issued under the A&R 2005 Plan (subject to approval of this Proposal 3 to authorize an additional 3,600,000 shares for issuance under the 2005 Plan), which may be authorized and unissued shares or treasury shares. The aggregate number of shares subject to awards granted to any one person in any calendar year may not exceed 600,000 shares. The maximum number of shares that may be granted subject to options is 25,000,000 shares (subject to approval of this Proposal 3).
50 | 2020 Proxy Statement
|
|
|
Share Counting. Shares covered by an award of restricted stock, restricted stock units, performance units, or a stock bonus are considered “Full Value” awards, and count against the maximum number of shares which may be issued under the A&R 2005 Plan as two shares for every one share granted or issued in payment of the award (2:1). Shares covered by a stock option or SARs that expire or terminate unexercised will be available again for awards under the A&R 2005 Plan. Shares granted as restricted stock or subject to a restricted stock unit award that are forfeited, cancelled, or otherwise are reacquired by us due to failure of the shares to vest will remain available for awards under the A&R 2005 Plan and will be added back in the same manner as the shares reduced the limit (2:1). Shares retained by us in payment of the exercise price of an award or withheld by us to satisfy tax withholding obligations will not be available again for awards under the A&R 2005 Plan. If a SAR or restricted stock unit award is settled by us entirely in cash, the shares covered by the award as to which the exercise or vesting occurs will be available again for awards under the A&R 2005 Plan.
Maximum Awards to Non-Employee Directors. The aggregate value (based on the grant date fair value as determined for financial accounting purposes) of awards granted to any non-employee director in any year may not exceed $250,000, and the maximum amount of cash compensation payable under the A&R 2005 Plan to any non-employee director in any year (determined at the time such cash compensation would be payable without respect to any election to defer payment to a subsequent year) is $250,000.
Adjustments. In the event of a change in our outstanding shares of common stock due to a stock dividend, stock split, recapitalization, merger, reorganization, or similar change, the Committee will make appropriate adjustments in: (a) the aggregate number of shares of common stock, (i) reserved for issuance, (ii) for which awards may be made to an individual, and (iii) covered by outstanding awards; (b) the exercise price relating to outstanding awards; and (c) the appropriate fair market value and other price determinations relevant to outstanding awards.
Stock Options. The A&R 2005 Plan permits the grant of incentive stock options and non-qualified stock options. The option exercise price per share may not be less than the fair market value of our common stock on the date of the grant. The type of option and other terms and conditions of the option will be determined by the Committee and set forth in the option agreement including the option term, subject to a maximum term of ten years. The Committee may determine when the option becomes exercisable and may accelerate previously established exercise rights. The agreement may permit payment of the option exercise price in one or more forms including cash, surrender, or withholding of shares of our common stock valued at their fair market value on the exercise date, or pursuant to a broker-assisted exercise program.
Unless otherwise provided in an option agreement, if an optionee's employment terminates for any reason other than death or disability, then the optionee generally may exercise an option to the extent it was exercisable at the time of the termination for a period of three months after the termination (but not after the expiration date of the option). However, the Committee has the power to terminate an optionee's rights under an outstanding option if optionee's employment was terminated for Cause or the optionee has engaged or may engage in employment or activities competitive with the Company or a subsidiary or contrary to our best interests. If termination of employment is on account of optionee's disability or death, the option will generally be exercisable after termination for six months due to disability and twelve months due to death, or the expiration date, if earlier.
If an optionee who is a non-employee director of the Company ceases to be our director for any reason other than retirement from the Board or death, then the optionee generally may exercise the option (to the extent that it was exercisable at the time the optionee ceased to be our director) for a period of three months (but not after the expiration date of the option). If an optionee who is our non-employee director ceases service (other than by reason of death) and at such time is at least age 65 with ten or more years of service or is at least age 70 with five or more years of service as a non-employee director, then the option generally will continue to be exercisable for five years or, if sooner, until the expiration of the option. If an optionee who is a non-employee director dies, then each outstanding but unexercised option held by the optionee for at least twelve months at the time of the optionee's death will become exercisable in full upon the optionee's death; and all options which are or become exercisable at the time of the optionee's death may be exercised by the optionee's estate or beneficiaries until the earlier of three years after the optionee's death or the expiration of the option. At the time of the granting of an option to a non-employee director, the Committee may make provisions for the exercise of the option if the optionee ceases to be a director of the Company which are different than those described above in this paragraph.
|
|
2020 Proxy Statement | 51
|
Stock Appreciation Rights. The Committee may grant SARs, which entitle the grantee to receive, upon the exercise of a SAR, an award equal to all or a portion of the excess of: (i) the fair market value of a specified number of shares of common stock at the time of the exercise over; (ii) a specified price not less than the fair market value of the common stock at the time the stock appreciation right was granted. SARs may be granted independently of or in connection with a stock option grant. Upon the exercise of a SAR, the applicable award may be paid in cash or in shares of common stock (or a combination thereof) as the Committee may determine. The maximum term of a SAR is ten years after the date of the grant. The Committee may determine when a SAR becomes exercisable and may accelerate previously established exercise rights.
The provisions of the A&R 2005 Plan relating to the exercisability of SARs upon termination of employment or service as a director are similar to those discussed in connection with stock options.
Performance Unit Awards. The Committee may grant performance unit awards (other than to non-employee directors) which provide for future payments based upon and subject to the achievement of pre-established long-term performance targets. The Committee will establish the: (i) performance period of not less than two or more than five years; (ii) value of each performance unit; and (iii) maximum and minimum performance targets to be achieved during the performance period. The Committee may adjust previously established performance targets or other terms and conditions of a performance unit award to reflect major unforeseen events or changes in circumstances. Performance unit awards, to the extent earned, may be paid in cash or shares of common stock (or a combination thereof) as the Committee may determine.
If the employment of a grantee of a performance unit award terminates prior to the end of an applicable performance period other than by reason of disability or death, then the award generally terminates. However, the A&R 2005 Plan permits the Committee to make partial payments of performance unit awards if the Committee determines such action to be equitable. If the employment of a grantee of a performance unit award terminates as a result of the grantee's disability or death prior to the end of an applicable performance period, then the Committee may authorize the payment of all or a portion of the performance unit award (to the extent earned under the applicable performance targets) to the grantee or the grantee's legal representative.
Restricted Stock Awards. The Committee may grant restricted stock awards consisting of shares of common stock restricted against transfer, subject to a substantial risk of forfeiture and to other terms and conditions. The Committee will determine the restriction period applicable to the restricted stock award and the amount, form, and time of payment (if any) required from the grantee of a restricted stock award in consideration of the issuance of the shares covered by such award. Generally, the Committee in its discretion may provide for the lapse of restrictions applicable to restricted stock awards and may waive the restrictions in whole or in part.
If the employment of a grantee of a restricted stock award terminates for any reason while some or all of the shares covered by such award are still restricted, then the grantee's rights with respect to the restricted shares generally terminate. However, the Committee has the discretion to provide for complete or partial exemptions to such employment requirement.
Restricted Stock Unit Awards. The Committee may grant restricted stock unit awards, which represent a right to receive future payments in either shares of our common stock or cash or a combination. The Committee determines the terms and conditions of the award. The Committee may grant restricted stock unit awards subject to the attainment of one or more performance goals, or may make the awards subject to time-based or other vesting conditions. Grantees have no voting rights or rights to receive cash dividends with respect to restricted stock unit awards until shares of common stock are issued in settlement of such awards. However, the Committee may grant restricted stock units that entitle holders to receive dividend equivalents, which are rights to receive additional restricted stock units based on the value of any cash dividends paid by us.
If the employment or service of a grantee of a restricted stock unit award terminates for any reason before some or all of the restricted stock units vest, then the grantee forfeits any unvested restricted stock units upon termination of employment. However, the Committee has the discretion to provide for complete or partial exemptions to such employment or service requirement.
52 | 2020 Proxy Statement
|
|
|
Stock Bonus Awards. The Committee may grant a stock bonus award (other than to non-employee directors) based upon the performance of the Company, a subsidiary or a segment thereof in terms of preestablished objective financial criteria or performance goals or, in appropriate cases, such other measures or standards of performance (including but not limited to performance already accomplished) as the Committee may determine. The Committee may adjust preestablished financial criteria or performance goals to take into account unforeseen events or changes in circumstances, but such adjustments may not increase the amount of a stock bonus award. The Committee, in its discretion, may impose additional restrictions upon the shares of common stock which are the subject of a stock bonus award.
Tax Withholding. The Company's obligation to deliver shares of common stock or make cash payments under the A&R 2005 Plan is subject to applicable tax withholding requirements. The Committee has discretion to require tax withholding amounts be paid by the grantee in cash or shares of common stock having a fair market value equal to the required tax withholding amount.
Non-Assignability. Awards may not be assigned or transferred by the recipient except by will, the laws of descent and distribution or, in the case of awards other than incentive stock options, pursuant to a qualified domestic relations order.
Termination and Amendment. Unless the A&R 2005 Plan is terminated earlier by the Board, it will terminate for purposes of further grants on May 17, 2028. Awards outstanding at the time of the termination will remain in effect in accordance with their terms. The Board may amend the A&R 2005 Plan at any time; however, stockholder approval must be obtained for any amendment for which approval is required in order to satisfy the applicable requirements of Section 16(b) of the Securities and Exchange Act of 1934, as amended, Section 422 of the Code or any regulation issued under any of such statutory provisions or the applicable requirements of any market or exchange on which shares of the common stock are listed or traded.
No Repricing. Stockholder approval is required to reduce the exercise price of an outstanding option or stock appreciation right or to cancel or amend an outstanding option or stock appreciation right for the purpose of repricing, replacing, or regranting such option or stock appreciation right with an exercise price which is lower than the original exercise price of such option or stock appreciation right. Additional information with respect to the matters discussed in this paragraph appears in section 22 of the A&R 2005 Plan.
U.S. Federal Income Tax Consequences Summary. The existing statutes, regulations and interpretations of applicable rules of federal income tax consequences are complex, and income tax consequences may vary depending upon the particular circumstances of each plan participant. The following summary describes federal income tax consequences of general applicability, but does not purport to describe particular consequences to each individual plan participant, or foreign, state or local income tax consequences, which may differ from the United States federal income tax consequences.
Incentive Stock Options. A recipient will not recognize income upon the grant of an incentive stock option. Also, except as described below, a recipient will not recognize income upon exercise of an incentive stock option if the recipient has been employed by our Company or its corporate parent or 50% or more-owned corporate subsidiary at all times beginning with the option grant date and ending three months before the date the recipient exercises the option. If the recipient has not been so employed during that time, then the recipient will be taxed as described below under "Non-Qualified Stock Options." The exercise of an incentive stock option may subject the recipient to alternative minimum tax.
A recipient will recognize income upon the sale of the stock acquired under an incentive stock option at a profit (if sales proceeds exceed the exercise price). The type of income will depend on when the recipient sells the stock. If a recipient sells the stock more than two years after the option was granted and more than one year after the option was exercised, then all of the profit will be long-term capital gain. If a recipient sells the stock prior to satisfying these waiting periods, then the recipient will have engaged in a disqualifying disposition and a portion of the profit will be ordinary income and a portion may be capital gain. This capital gain will be long-term if the recipient has held the stock for more than one year. If a recipient sells the stock at a loss (sales proceeds are less than the exercise price), then the loss will be a capital loss. This capital loss will be long-term if the recipient held the stock for more than one year.
|
|
2020 Proxy Statement | 53
|
Non-Qualified Stock Options. A recipient will not recognize income upon the grant of a non-qualified stock option. A recipient will recognize compensation income upon the exercise of a non-qualified stock option equal to the value of the stock on the day the recipient exercised the option less the exercise price. Upon sale of the stock, the recipient will recognize capital gain or loss equal to the difference between the sales proceeds and the value of the stock on the day the option was exercised. This capital gain or loss will be long-term if the recipient has held the stock for more than one year.
Stock Appreciation Rights. A recipient will not recognize income upon the grant of a SAR. A recipient generally will recognize compensation income upon the exercise of a SAR equal to the amount of the cash and the fair market value of any stock received. Upon the sale of the stock, the recipient will recognize capital gain or loss equal to the difference between the sales proceeds and the value of the stock on the day the SAR was exercised. This capital gain or loss will be long-term if the recipient held the stock for more than one year.
Restricted Stock Awards. A recipient will not recognize income upon the grant of restricted stock that is subject to vesting conditions unless an election under Section 83(b) of the Code is made within thirty days of the date of grant. If a timely 83(b) election is made, then a recipient will recognize compensation income equal to the value of the stock less any purchase price paid for the stock. Upon sale of the stock, the recipient will recognize capital gain or loss equal to the difference between the sales proceeds and the value of the stock on the date of grant. This capital gain or loss will be long-term if the recipient held the stock for more than one year. If the stock is forfeited due to the failure to satisfy the vesting conditions, then the recipient would not receive any deduction or loss with respect to the amount included in income by reason of the Section 83(b) election.
If the recipient does not make an 83(b) election, then as the vesting conditions become satisfied, the recipient will recognize compensation income equal to the value of the stock on the vesting date, less any purchase price paid for the stock. Upon sale of the stock, the recipient will recognize capital gain or loss equal to the sales proceeds less the value of the stock on the vesting date. Any capital gain or loss will be long-term if the recipient held the stock for more than one year.
Restricted Stock Units. A recipient will not recognize income upon the grant of a restricted stock unit award. A recipient is not permitted to make a Section 83(b) election with respect to a restricted stock unit award. When the restricted stock unit award vests, the recipient will recognize income on the date the stock is transferred to the recipient in an amount equal to the fair market value of the stock on such date less the purchase price, if any, paid for the stock. Upon sale of the stock, the recipient will recognize capital gain or loss equal to the sales proceeds less the value of the stock on the date of transfer. Any capital gain or loss will be long-term if the recipient held the stock for more than one year. The tax consequences for non-U.S. based employees receiving restricted stock unit awards could be materially different than described above based on the foreign jurisdiction laws and regulations in effect at the time of grant and vest.
Other Stock-Based Awards. The tax consequences associated with any other stock-based award granted under the A&R 2005 Plan will vary depending on the specific terms of the award. Among the relevant factors are whether or not the award has a readily ascertainable fair market value, whether or not the award is subject to forfeiture provisions or restrictions on transfer, the nature of the property to be received by the recipient under the award and the recipient's holding period and tax basis for the award or underlying common stock.
Tax Consequences to the Company. We generally will be entitled to an equivalent deduction to the extent that a recipient recognizes compensation income. Any such deduction may be subject to limitations under the Internal Revenue Code, including Section 162(m).
NEW PLAN BENEFITS
All awards to eligible participants under the A&R 2005 Plan are made at the discretion of the Committee. Therefore, the future benefits and amounts that will be received or allocated to such individuals under the A&R 2005 Plan are not determinable at this time. For information regarding awards granted to our NEOs in the last fiscal year under the 2005 Plan, see the 2019 Grants of Plan-Based Awards Table and for awards granted to our non-employee independent directors during the last fiscal year under the 2005 Plan, see the 2019 Director Compensation Table.
54 | 2020 Proxy Statement
|
|
|
EQUITY COMPENSATION PLAN INFORMATION
The following table summarizes certain information about our equity compensation plans as of December 31, 2019, which consists solely of our 2005 Plan and our Second Amended and Restated 1996 Employee Stock Purchase Plan (the “ESPP”):
Plan Category
|
|
Number of securities to be
issued upon exercise of
outstanding options,
warrants, and rights
|
|
|
Weighted-average exercise
price of outstanding
options, warrants, and rights
|
|
|
Number of securities
remaining available for
future issuance (1)
|
|
Equity compensation plans approved by security holders
|
|
|
|
|
$
|
|
|
|
3,660,880
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Of the total number of securities remaining available for future issuance, 3,438,620 shares can be used for various types of stock-based awards, as specified in the Plan, with the remaining 222,260 shares to be used for our ESPP.
|
The Board Recommends a Vote FOR the Approval of the Amended and Restated 2005 Stock Incentive Plan.
|
|
2020 Proxy Statement | 55
|
PROPOSAL 4 – RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL 2020
KPMG LLP has served as our independent registered public accounting firm since 2002 and has been appointed by the Audit Committee to serve in such capacity for 2020. The Company expects that representatives of KPMG LLP will be present at the Annual Meeting, with the opportunity to make a statement if they desire to do so, and that such representatives will be available to respond to appropriate questions.
The following table sets forth: (1) as “Audit Fees,” the aggregate fees billed by KPMG LLP for 2019 and 2018 for professional services rendered for audits of our annual consolidated financial statements and reviews of financial statements included in the Company’s Quarterly Reports on Form 10-Q as well as for services that are normally provided by KPMG LLP in connection with statutory and regulatory filings or engagements for such periods, such as the attestation on the effectiveness of the Company’s internal control over financial reporting; (2) as “Audit-Related Fees,” the aggregate fees billed by KPMG LLP in 2019 and 2018 for assurance and related services that are reasonably related to the performance of the audits or reviews of the Company’s financial statements that are not reported under “Audit Fees;” and (3) as “Tax Fees,” the aggregate fees billed by KPMG LLP in 2019 and 2018 for federal, state, and foreign tax compliance, tax advice, and tax planning services:
|
|
2019
|
|
|
2018
|
|
Audit Fees
|
|
$
|
1,742,940
|
|
|
$
|
1,745,480
|
|
Audit-Related Fees
|
|
|
617,810
|
|
|
|
480,000
|
|
Tax Fees
|
|
|
81,190
|
|
|
|
127,340
|
|
Total Fees
|
|
$
|
2,441,940
|
|
|
$
|
2,352,820
|
|
|
|
|
|
|
|
|
|
|
Other than as reported above, no other fees were billed by KPMG LLP for 2019 or 2018. All of the services listed above were pre-approved by the Audit Committee under the procedures described below.
PRE-APPROVAL POLICIES AND PROCEDURES
The Audit Committee charter requires the Audit Committee to approve, in advance of the performance of the services, all audit and permissible non-audit related services to be provided to the Company by the Company’s independent registered public accounting firm. The Audit Committee has delegated to its Chair the authority to perform the Audit Committee’s responsibilities with respect to such approvals. The Audit Committee Chair is required to report to the Audit Committee at its next meeting on the manner in which such delegated performance was carried out by him. Each year since 2002, the engagement of KPMG LLP to provide services to the Company has been approved in advance either by the Audit Committee or by its Chair pursuant to the delegated authority referred to above.
The Audit Committee annually evaluates the performance of its independent registered public accounting firm and determines whether to re-engage the current independent auditors or consider other independent audit firms.
Factors considered by the Audit Committee in deciding whether to retain the current independent auditors include:
|
▪
|
quality of service and sufficiency of resources;
|
|
▪
|
communication and interaction; and
|
|
▪
|
independence, objectivity, and professional skepticism.
|
Based on this evaluation, the Audit Committee and the Board believe that retaining KPMG LLP to serve as our independent registered public accounting firm for the fiscal year ending December 31, 2020, is in the best interests of our Company and its stockholders.
Although the Company’s Audit Committee is directly responsible for the appointment of the Company’s independent registered public accounting firm, the Board is requesting the Company’s stockholders to ratify the Audit Committee’s appointment of KPMG LLP to serve in such capacity for 2020 so that the Company will have the benefit of its stockholders’ views on such appointment. If the stockholders do not ratify such appointment, the Audit Committee nevertheless may determine that it is in the best interests of the Company and its stockholders to keep such appointment in effect for 2020. Whether or not the appointment of KPMG LLP is ratified by the stockholders, the Audit Committee at any time during the year may appoint a different independent registered public accounting firm for 2020 if the Audit Committee determines that such a change would be in the best interests of the Company and its stockholders.
The Board Recommends That Stockholders Vote FOR Ratification of the Appointment of KPMG LLP
As Our Independent Registered Public Accounting Firm for Fiscal 2020.
56 | 2020 Proxy Statement
|
|
|
REPORT OF THE AUDIT COMMITTEE
The primary purposes of the Audit Committee, as set forth in its charter, are to oversee the accounting and financial reporting processes of the Company and the audits of the consolidated financial statements of the Company and to provide oversight of our risk and compliance management programs.
We have implemented procedures to assist the Audit Committee with its responsibilities under its charter. During 2019 and thereafter through the completion of the audit of the Company’s consolidated financial statements for such year, those procedures included regular meetings with management of the Company and with appropriate representatives of the Company’s independent registered public accounting firm.
We reviewed and discussed both with management of the Company and with the Company’s independent registered public accounting firm, KPMG LLP, the Company’s audited consolidated financial statements for the year ended December 31, 2019.
We also discussed with KPMG LLP the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board and the SEC.
We received the written disclosures and the letter from KPMG LLP required by the applicable requirements of the Public Company Accounting Oversight Board regarding KPMG LLP’s communications with the Audit Committee concerning independence, and have discussed with KPMG LLP its independence.
Based upon the reviews and discussions referred to in the immediately preceding three paragraphs of this report, we recommended to the Board that the audited consolidated financial statements of the Company as of and for the year ended December 31, 2019, be included in the Company’s Annual Report on Form 10-K for such year for filing with the SEC.
Audit Committee of the Board of Directors:
David G. Barnes, Chair
Ronald H. Cooper
Janice I. Obuchowski
Donald B. Reed
|
|
2020 Proxy Statement | 57
|
RELATED PARTY TRANSACTIONS
Our Audit Committee charter requires the Audit Committee to review and approve all related party transactions. For purposes of the charter, the term “related party transactions” includes all transactions required to be disclosed pursuant to Item 404 of SEC Regulation S-K.
There were no related party transactions during 2019 and there are not any currently proposed transactions, in which the Company was or is a participant with any related person, which would be required to be disclosed pursuant to Item 404 of SEC Regulation S-K.
STOCKHOLDER PROPOSALS
A stockholder who would like to have a proposal considered for inclusion in our 2021 proxy statement pursuant to SEC rules must submit the proposal so that it is received by us no later than December 8, 2020, unless the date of our 2021 annual meeting of stockholders is more than 30 days before or after May 21, 2021, in which case the proposal must be received a reasonable time before we begin to print and send our proxy materials. SEC rules set standards for eligibility and specify the types of stockholder proposals that may be excluded from a proxy statement. Stockholder proposals should be addressed to the Secretary, CSG Systems International, Inc., 6175 S. Willow Drive, Greenwood Village, CO 80111.
In addition, for stockholder proposals and stockholder nominations submitted outside of the SEC proposal rules, our bylaws require that advance written notice in proper form for matters to be brought before an annual stockholders meeting be received by the Secretary of the Company not less than 120 days before the first anniversary date of our proxy statement being released to stockholders in connection with the previous year’s annual meeting of stockholders. Accordingly, notice of stockholder proposals for the 2021 annual meeting must be received by us no later than December 8, 2020. If the date of our 2021 annual meeting is changed by more than 30 days from May 21, 2021, proper notice of stockholder proposals and nominations must be received as provided for in our bylaws.
Our bylaws also provide that stockholder nominations of persons for election to the Board are subject to certain informational requirements. Copies of our bylaws are available to stockholders upon request made to our Secretary at the above address.
HOUSEHOLDING
We have adopted a procedure called “householding.” This practice allows us to deliver only one copy of proxy-related materials, annual reports, and information statements to stockholders who share the same address and last name and who do not participate in e-mail delivery of these materials, unless one or more stockholders notifies us that he or she would like to receive an individual copy. If you share an address with another stockholder and receive only one set of proxy-related materials and would like to request a separate copy for this year’s Annual Meeting or for future meetings or stockholder communications, please send your written request to CSG Systems International, Inc., 6175 S. Willow Drive, Greenwood Village, CO 80111, Attn: Investor Relations Department, or call us at (303) 200-2000. Upon request, we will promptly deliver a separate copy to you. Similarly, you may also contact us through either of these methods if you receive multiple copies of proxy-related materials and other stockholder communications and would prefer to receive a single copy in the future.
58 | 2020 Proxy Statement
|
|
|
ANNUAL REPORT ON FORM 10-K AND OTHER SEC FILINGS
A copy of our 2019 Annual Report on Form 10-K is included in the proxy materials and is also available on our website on the Investor Relations page (located at https://ir.csgi.com/investors/financials/sec-filings). If you request, we will provide you with a separate copy of our 2019 Annual Report on Form 10-K for the year ended December 31, 2019, without charge. You should send your written requests to our Investor Relations department at the address on page 58 of this proxy statement or contact the Investor Relations department at (303) 200-2000. The 2019 Annual Report on Form 10-K does not constitute and should not be considered a part of this proxy statement.
OTHER MATTERS
As of the date of this proxy statement, we are not aware of any matter that may come before the Annual Meeting other than the matters discussed in this proxy statement; however, if any other matter is properly presented at the Annual Meeting, the persons named in the accompanying proxy or their substitutes will have discretionary authority to vote on such matter in accordance with their judgment.
By Order of the Board of Directors
Gregory L. Cannon
Secretary
April 7, 2020
ALL STOCKHOLDERS AS OF THE RECORD DATE ARE WELCOME TO ATTEND THE ANNUAL MEETING; HOWEVER, REGARDLESS OF WHETHER YOU PLAN TO ATTEND THE ANNUAL MEETING, PLEASE COMPLETE, DATE, AND SIGN THE ENCLOSED PROXY AND MAIL IT PROMPTLY IN THE ACCOMPANYING ENVELOPE IN ORDER TO ENSURE REPRESENTATION OF YOUR SHARES. NO POSTAGE IS REQUIRED IF THE ACCOMPANYING ENVELOPE IS MAILED IN THE UNITED STATES.
YOU ALSO MAY FILE YOUR PROXY BY TELEPHONE OR THE INTERNET IN ACCORDANCE WITH THE INSTRUCTIONS ACCOMPANYING THE PROXY AND NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIALS.
IF YOU ATTEND THE ANNUAL MEETING AND ARE A STOCKHOLDER OF RECORD, YOU MAY VOTE ONLINE AT THE ANNUAL MEETING. IF YOU WISH TO ATTEND AND VOTE AT THE ANNUAL MEETING AND YOUR SHARES ARE HELD IN “STREET NAME,” YOU WILL NEED TO OBTAIN A PROXY FROM THE INSTITUTION THAT HOLDS YOUR SHARES AND SHOULD ADVISE SUCH INSTITUTION NOT TO VOTE YOUR SHARES. A PROXY WHICH YOU GIVE WILL NOT BE USED IF YOU ATTEND THE ANNUAL MEETING AND SO REQUEST.
|
|
2020 Proxy Statement | 59
|
APPENDIX A
CSG SYSTEMS INTERNATIONAL, INC.
AMENDED AND RESTATED 2005 STOCK INCENTIVE PLAN
(As Amended and Restated Effective May 21, 2020)
1. Purpose. The purpose of the CSG Systems International, Inc. 2005 Stock Incentive Plan (the “Plan”), as amended and restated, is to foster and promote the long‑term financial success of the Company and its Subsidiaries and thereby increase stockholder value by providing incentives to those officers and other key employees of the Company and its Subsidiaries who are likely to be responsible for achieving such financial success and by attracting and compensating knowledgeable and experienced non‑employee directors of the Company whose services on the Board and its committees can assist such officers and other key employees in the achievement of such financial success.
2. Certain Definitions.
“Board” means the Board of Directors of the Company.
“Code” means the Internal Revenue Code of 1986, as amended from time to time, or any successor thereto. References to a particular section of the Code shall include any regulations issued under such section.
“Committee” shall have the meaning provided in Section 3 of the Plan.
“Common Stock” means the Common Stock, $0.01 par value per share, of the Company.
“Company” means CSG Systems International, Inc., a Delaware corporation.
“Disability” means (i) with respect to the exercise of an Incentive Stock Option after termination of employment, a disability within the meaning of Section 22(e)(3) of the Code and (ii) for all other purposes, a mental or physical condition which, in the opinion of the Committee, renders a grantee unable or incompetent to carry out the job responsibilities which such grantee held or the tasks to which such grantee was assigned (or, in the case of a non‑employee director of the Company, the services in such capacity which such non‑employee director is expected to perform) at the time the disability was incurred and which is expected to be permanent or for an indefinite duration exceeding one year.
“Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time.
“Fair Market Value” means, as determined by the Committee, the last sale price of the Common Stock as quoted on the NASDAQ Stock Market on the trading day for which the determination is being made, or, in the event that no such sale takes place on such day, the average of the reported closing bid and asked prices on the NASDAQ Stock Market on such day, or, if the Common Stock of the Company is listed on another national securities exchange, the last reported sale price on the principal national securities exchange on which the Common Stock is listed or admitted to trading on the trading day for which the determination is being made, or, if no such reported sale takes place on such day, the average of the closing bid and asked prices on such day on the principal national securities exchange on which the Common Stock is listed or admitted to trading, or, if the Common Stock is not quoted on the NASDAQ Stock Market nor listed or admitted to trading on another national securities exchange, the average of the closing bid and asked prices in the over‑ the‑counter market on the day for which the determination is being made as reported through NASDAQ, or, if bid and asked prices for the Common Stock on such day are not reported through NASDAQ, the average of the bid and asked prices for such day as furnished by any New York Stock Exchange member firm regularly making a market in the Common Stock selected for such purpose by the Committee, or, if none of the foregoing is applicable, then the fair market value of the Common Stock as determined in good faith by the Committee in its sole discretion.
60 | 2020 Proxy Statement
|
|
|
Appendix A
“Incentive Stock Option” means any stock option intended to qualify as an “incentive stock option” within the meaning of Section 422 of the Code.
“Non‑Qualified Stock Option” means any stock option that is not intended to be an Incentive Stock Option, including any stock option that provides (as of the time such option is granted) that it will not be treated as an Incentive Stock Option.
“Parent Corporation” means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company if, at the time of the granting of the option, each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.
“Performance Unit Award” means an award granted pursuant to Section 8.
“Plan Year” means the twelve‑month period beginning on January 1 and ending on December 31.
“Restricted Stock Award” means an award of Common Stock granted pursuant to Section 9.
“Restricted Stock Unit Award” means an award granted pursuant to Section 10.
“Rule 16b‑3” means Rule 16b‑3 under the Exchange Act, as in effect from time to time.
“Stock Appreciation Right” means an award granted pursuant to Section 7.
“Stock Bonus Award” means an award of Common Stock granted pursuant to Section 11.
“Stock Option” means any option to purchase Common Stock granted pursuant to Section 6.
“Subsidiary” means (i) as it relates to Incentive Stock Options, any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company if, at the time of the granting of the option, each of the corporations (other than the last corporation in the unbroken chain) owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain and (ii) for all other purposes, a corporation or other entity, domestic or foreign, of which not less than 50% of the voting shares or other voting interests are held by the Company or by a Subsidiary, whether or not such corporation or other entity now exists or hereafter is organized or acquired by the Company or by a Subsidiary. The plural form of such word is “Subsidiaries”.
3. Administration. The Plan shall be administered by a committee composed solely of two or more members of the Board (the “Committee”) selected by the Board, each of whom shall qualify as a “Non‑Employee Director” within the meaning of Rule 16b‑3.
The Committee shall have authority to grant to eligible employees of the Company and its Subsidiaries and to non‑employee directors of the Company, pursuant to the terms of the Plan, (a) Stock Options, (b) Stock Appreciation Rights, (c) Performance Unit Awards, (d) Restricted Stock Awards, (e) Restricted Stock Unit Awards, (f) Stock Bonus Awards, or (g) any combination of the foregoing; provided, that the Committee may not grant Incentive Stock Options, Performance Unit Awards, or Stock Bonus Awards to non‑employee directors of the Company.
Subject to the applicable provisions of the Plan, the Committee shall have authority to interpret the provisions of the Plan and to decide all questions of fact arising in the application of such provisions; to select the officers and other key employees of the Company and its Subsidiaries and the non‑employee directors of the Company to whom awards or options shall be granted under the Plan; to determine whether and to what extent awards or options shall be granted under the Plan; to determine the types of awards and options to be granted under the Plan and the amount, size, terms,
|
|
2020 Proxy Statement | 61
|
Appendix A
and conditions of each such award or option; to determine the time when awards or options shall be granted under the Plan; to determine whether, to what extent, and under what circumstances the payment of Common Stock and other amounts payable with respect to an award granted under the Plan shall be deferred either automatically or at the election of the grantee; to determine the Fair Market Value of the Common Stock from time to time; to authorize persons to execute on behalf of the Company any agreement required to be entered into under the Plan; to adopt, alter, and repeal such administrative rules, guidelines, and practices governing the Plan as the Committee from time to time shall deem advisable; and to make all other determinations and take all other actions necessary or advisable for the administration of the Plan.
Unless otherwise expressly provided in the Plan or by applicable law, all decisions and determinations made by the Committee in the administration and interpretation of the Plan or with respect to any ambiguous or disputed terms of any award or option shall be made in the sole discretion of the Committee and shall be final and binding on all persons, including but not limited to the Company and its Subsidiaries, the officers and other key employees of the Company and its Subsidiaries and the non‑employee directors of the Company to whom awards and options are granted under the Plan, the heirs and legal representatives of such officers, key employees, and non‑employee directors, and the personal representatives and beneficiaries of the estates of such officers, key employees, and non‑employee directors.
The Committee may, in its sole discretion, vary the provisions of the Plan (except the provisions of Sections 4, 13, 14, 21 (other than to require a grantee’s consent to an amendment of an outstanding option or award), and 24 of the Plan) in order to conform such provisions to the legal requirements of each non‑U.S. jurisdiction where a Subsidiary is located or to better accomplish the purpose of the Plan (including but not limited to the tax treatment of grantees of awards and options) with respect to (i) persons employed in such non‑U.S. jurisdictions who are eligible to receive awards and options under the Plan and (ii) non‑employee directors of the Company who reside in non‑U.S. jurisdictions. The Committee may, where it deems appropriate in its sole discretion, establish one or more sub‑plans for such purposes; and the Committee may, in its sole discretion, establish administrative rules and procedures to facilitate the operation of the Plan or such sub‑plans in such non‑U.S. jurisdictions. For purposes of clarity, the terms of the Plan which will vary in a particular non‑U.S. jurisdiction shall be reflected in a written addendum to the Plan for such non‑U.S. jurisdiction.
The Committee may delegate to any officer or officers of the Company any of the Committee’s duties, powers, and authorities under the Plan upon such conditions and with such limitations as the Committee may determine; provided, that only the Committee may select for awards or options under the Plan, and make grants of awards or options under the Plan to, (i) officers and other key employees of the Company or any Subsidiary who are subject to Section 16 of the Exchange Act at the time of such selection or the making of such a grant and (ii) non‑employee directors of the Company.
4. Common Stock Subject to the Plan. Subject to adjustment pursuant to Section 20, the maximum number of shares of Common Stock which may be issued under the Plan is 25,000,000; and the Company shall reserve and keep available for issuance under the Plan such maximum number of shares, subject to adjustment pursuant to Section 20. Such shares may consist in whole or in part of authorized and unissued shares or treasury shares or any combination thereof. Shares of Common Stock subject to a Stock Option or a Stock Appreciation Right granted under the Plan shall be counted against the maximum number of shares of Common Stock which may be issued under the Plan as one share for each share subject to the Stock Option or the Stock Appreciation Right. Shares awarded under the Plan as a Performance Unit Award, Restricted Stock Award, Restricted Stock Unit Award, or Stock Bonus Award shall be counted against the maximum number of shares of Common Stock which may be issued under the Plan as two shares for each one share granted as or subject to such Award. Subject to adjustment pursuant to Section 20, the aggregate number of shares of Common Stock subject to (i) Stock Options, (ii) Stock Appreciation Rights, (iii) Performance Unit Awards, (iv) Restricted Stock Awards, (v) Restricted Stock Unit Awards, or (vi) Stock Bonus Awards granted under the Plan in any Plan Year to any individual may not exceed 600,000, with shares awarded under the Plan to such individual as a Performance Unit Award, Restricted Stock Award, Restricted Stock Unit Award, or Stock Bonus Award being counted against such aggregate number as two shares for each one share granted as or subject to such Award. Notwithstanding anything in the Plan to the contrary, (a) the aggregate value (based on the grant date fair value as determined for financial reporting purposes) of Awards granted under the Plan in any Plan Year to any non-employee director shall not exceed $250,000, and (b) the maximum amount of cash compensation payable by the Company to any non-employee director in any Plan Year (determined at the time such cash compensation would be payable without regard to any election to defer payment to a subsequent year, shall be $250,000.
62 | 2020 Proxy Statement
|
|
|
Appendix A
Except as otherwise provided in the Plan, any shares as to which a Stock Option or Stock Appreciation Right expires for any reason or terminates unexercised shall be available again for the grant of awards or options under the Plan. If any shares of Common Stock granted as a Restricted Stock Award or subject to a Restricted Stock Unit Award are forfeited, cancelled, or otherwise reacquired by the Company by reason of the failure of such shares to vest in the grantee of such Award, then the number of shares of Common Stock which then remain available for issuance under the Plan shall be increased by two shares for each one share so forfeited, cancelled, or otherwise reacquired by the Company. Shares of Common Stock retained by the Company in full or partial payment of an option exercise price pursuant to Section 6(d)(ii)(B) or withheld by the Company in satisfaction of any federal, state, or local tax withholding requirement shall not be available again for the grant of awards or options under the Plan. If a Stock Appreciation Right is exercised by a grantee or a Restricted Stock Unit Award vests in a grantee and the Company pays the award to the grantee entirely in cash, then the shares covered by the Stock Appreciation Right or Restricted Stock Unit Award as to which such exercise or vesting occurs shall be available again for the grant of awards or options under the Plan. If a Stock Appreciation Right is exercised by a grantee as to some or all of the shares covered by such Stock Appreciation Right and the Company pays the exercised award to the grantee in whole or in part in shares of Common Stock, then none of the shares as to which such exercise occurs will again be available for the grant of awards or options under the Plan.
5. Eligibility to Receive Awards and Options. Awards and options may be granted under the Plan to those officers and other key employees of the Company or any Subsidiary who are responsible for or contribute to, or are likely to be responsible for or contribute to, the management, growth, and success of the Company or any Subsidiary and to non‑employee directors of the Company. The granting of an award or option under the Plan to an officer or other key employee of the Company or any Subsidiary shall conclusively evidence the Committee’s determination that such grantee meets one or more of the criteria referred to in the preceding sentence.
6. Stock Options. A Stock Option may be an Incentive Stock Option or a Non‑Qualified Stock Option. To the extent that any Stock Option does not qualify as an Incentive Stock Option, it shall constitute a separate Non‑Qualified Stock Option. Stock Options may be granted alone or in addition to other awards made under the Plan. Stock Options shall be evidenced by agreements in such form as the Committee shall approve from time to time. The agreements shall contain in substance the following terms and conditions and may contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem appropriate:
(a) Type of Option. Each option agreement shall identify the Stock Option represented thereby as an Incentive Stock Option or a Non‑Qualified Stock Option, as the case may be. All of the shares of Common Stock authorized for issuance under the Plan may be issued pursuant to Incentive Stock Options.
To the extent that the aggregate Fair Market Value (determined as of the time the option is granted) of the Common Stock with respect to which Incentive Stock Options granted under the Plan (and all other plans of the Company and its Subsidiaries) become exercisable for the first time by any individual in any calendar year exceeds $100,000, such Stock Options shall be treated as Non‑ Qualified Stock Options. No Incentive Stock Option shall be granted to any employee if, at the time the option is granted, the employee (in his or her own right or by reason of the attribution rules applicable under Section 424(d) of the Code) owns more than 10% of the total combined voting power of all classes of stock of the Company or any Parent Corporation or Subsidiary unless at the time such option is granted the option price is at least 110% of the Fair Market Value of the stock subject to such Stock Option and such Stock Option by its terms is not exercisable after the expiration of five years from the date of its grant.
(b) Option Price. The option exercise price per share shall not be less than the Fair Market Value of the Common Stock on the date the Stock Option is granted and in no event shall be less than the par value of the Common Stock.
|
|
2020 Proxy Statement | 63
|
Appendix A
(c) Term. Each option agreement shall state the period or periods of time within which the Stock Option may be exercised, in whole or in part, which shall be such period or periods of time as the Committee may determine at the time of the Stock Option grant; provided, that no Stock Option granted under the Plan shall be exercisable more than ten years after the date of its grant; and provided further, that each Stock Option granted under the Plan shall become exercisable one year after the date of its grant, unless the option agreement specifically provides otherwise. The Committee shall have authority to accelerate previously established exercise rights, subject to the requirements set forth in the Plan, under such circumstances and upon such terms and conditions as the Committee shall deem appropriate.
(d) Payment for Shares. The Committee may permit all or part of the payment of the option exercise price to be made (i) in cash, by check, or by wire transfer or (ii) in shares of Common Stock (A) which already are owned by the optionee and which are surrendered to the Company in good form for transfer or (B) which are retained by the Company from the shares of the Common Stock which would otherwise be issued to the optionee upon the optionee’s exercise of the Stock Option. Such shares shall be valued at their Fair Market Value on the date of exercise of the Stock Option. In lieu of payment in fractions of shares, payment of any fractional share amount shall be made in cash or check payable to the Company. The Committee also may provide that the exercise price may be paid by delivering a properly executed exercise notice in a form approved by the Committee together with irrevocable instructions to a broker to promptly deliver to the Company the amount of the applicable sale or loan proceeds required to pay the exercise price. No shares of Common Stock shall be issued to any optionee upon the exercise of a Stock Option until the Company receives full payment therefor as described above.
(e) Rights upon Termination of Employment. In the event that an optionee ceases to be employed either by the Company or by a Subsidiary for any reason other than such optionee’s death or Disability, any rights of the optionee under any Stock Option then in effect immediately shall terminate; provided, that the optionee (or the optionee’s legal representative) shall have the right to exercise the Stock Option during its term within a period of three months after such termination of employment to the extent that the Stock Option was exercisable at the time of such termination or within such other period and subject to such other terms and conditions as may be specified by the Committee. Notwithstanding the foregoing provisions of this Section 6(e), the optionee (and the optionee’s legal representative) shall not have any rights under any Stock Option, and the Company shall not be obligated to sell or deliver shares of Common Stock (or have any other obligation or liability) under any Stock Option, if the Committee shall determine that (i) the employment of the optionee with the Company or any Subsidiary has been terminated for cause or (ii) the optionee has engaged or may engage in employment or activities competitive with the Company or any Subsidiary or contrary, in the opinion of the Committee, to the best interests of the Company or any Subsidiary. In the event of such determination, the optionee (and the optionee’s legal representative) shall have no right under any Stock Option to purchase any shares of Common Stock regardless of whether the optionee (or the optionee’s legal representative) shall have delivered a notice of exercise prior to the Committee’s making of such determination. Any Stock Option may be terminated entirely by the Committee at the time of or at any time subsequent to a determination by the Committee under this Section 6(e) which has the effect of eliminating the Company’s obligation to sell or deliver shares of Common Stock under such Stock Option.
In the event that an optionee ceases to be employed either by the Company or by a Subsidiary by reason of such optionee’s Disability, prior to the expiration of a Stock Option and without such optionee’s having fully exercised such Stock Option, such optionee or such optionee’s legal representative shall have the right to exercise such Stock Option during its term within a period of six months after such termination of employment to the extent that such Stock Option was exercisable at the time of such termination or within such other period and subject to such other terms and conditions as may be specified by the Committee.
64 | 2020 Proxy Statement
|
|
|
Appendix A
In the event that an optionee ceases to be employed either by the Company or by a Subsidiary by reason of such optionee’s death, prior to the expiration of a Stock Option and without such optionee’s having fully exercised such Stock Option, the personal representative of such optionee’s estate or the person who acquired the right to exercise such Stock Option by bequest or inheritance from such optionee shall have the right to exercise such Stock Option during its term within a period of twelve months after the date of such optionee’s death to the extent that such Stock Option was exercisable at the time of such death or within such other period and subject to such other terms and conditions as may be specified by the Committee.
The foregoing provisions of this Section 6(e) shall not be applicable to non‑employee directors of the Company.
(f) Rights Upon Termination of Service as a Director. Unless the applicable option agreement provides otherwise, if an optionee who is a non‑employee director of the Company ceases to be a director of the Company for any reason other than retirement from the Board under the circumstances described in the following paragraph of this Section 6(f) or death, then each outstanding but unexercised Stock Option held by such optionee shall continue to be exercisable only to the extent that it was exercisable at the time that such optionee ceased to be a director of the Company and only until the earlier of (i) three months after such optionee ceased to be a director of the Company or (ii) the expiration of the term of such Stock Option.
Unless the applicable option agreement provides otherwise, if an optionee who is a non‑employee director of the Company ceases to be a director of the Company (other than by reason of death) and at the time of such occurrence (the “Retirement Date”) is at least age 65 with ten or more years of service as a non‑employee director of the Company or is at least age 70 with five or more years of service as a non‑employee director of the Company, then each outstanding but unexercised Stock Option held by such optionee on the Retirement Date shall continue to be or become exercisable in accordance with its terms until the earlier of (i) five years after the Retirement Date or (ii) the expiration of the term of such Stock Option.
Unless the applicable option agreement provides otherwise, if an optionee who is a non‑employee director of the Company dies, then each outstanding but unexercised Stock Option which had been held by such grantee for at least twelve months as of the date of such optionee’s death automatically shall become exercisable in full (if not already exercisable) upon such optionee’s death. Each outstanding but unexercised Stock Option which becomes exercisable pursuant to the preceding sentence and each outstanding but unexercised Stock Option held by such optionee which was exercisable on the date of such optionee’s death may be exercised by the legal representative of such optionee’s estate or by the beneficiaries of such estate to whom such Stock Option is distributed until the earlier of (i) three years after the date of such optionee’s death or (ii) the expiration of the term of such Stock Option.
The foregoing provisions of this Section 6(f) shall be applicable only to non‑employee directors of the Company.
7. Stock Appreciation Rights. Stock Appreciation Rights shall enable the grantees thereof to benefit from increases in the Fair Market Value of shares of Common Stock and shall be evidenced by agreements in such form as the Committee shall approve from time to time. The agreements shall contain in substance the following terms and conditions and may contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem appropriate:
(a) Award. A Stock Appreciation Right shall entitle the grantee, subject to such terms and conditions as the Committee may prescribe, to receive upon the exercise thereof an award equal to all or a portion of the excess of (i) the Fair Market Value of a specified number of shares of Common Stock at the time of the exercise of such right over (ii) a specified price which shall not be less than the Fair Market Value of the Common Stock at the time the right is granted. Subject to the limitations set forth in Section 4, such award may be paid by the Company in cash, in shares of Common Stock (valued at their then Fair Market Value), or in any combination thereof, as the Committee may determine. Stock Appreciation Rights may be, but are not required to be, granted in connection with a previously or contemporaneously granted Stock Option.
|
|
2020 Proxy Statement | 65
|
Appendix A
(b) Term. Each agreement shall state the period or periods of time within which the Stock Appreciation Right may be exercised, in whole or in part, subject to such terms and conditions prescribed for such purpose by the Committee; provided, that no Stock Appreciation Right shall be exercisable more than ten years after the date of its grant; and provided further, that each Stock Appreciation Right granted under the Plan shall become exercisable one year after the date of its grant, unless the agreement specifically provides otherwise. The Committee shall have authority to accelerate previously established exercise rights, subject to the requirements set forth in the Plan, under such circumstances and upon such terms and conditions as the Committee shall deem appropriate.
(c) Rights upon Termination of Employment. In the event that a grantee of a Stock Appreciation Right ceases to be employed either by the Company or by a Subsidiary for any reason other than such grantee’s death or Disability, any rights of the grantee under any Stock Appreciation Right then in effect immediately shall terminate; provided, that the grantee (or the grantee’s legal representative) shall have the right to exercise the Stock Appreciation Right during its term within a period of three months after such termination of employment to the extent that the Stock Appreciation Right was exercisable at the time of such termination or within such other period and subject to such other terms and conditions as may be specified by the Committee. Notwithstanding the foregoing provisions of this Section 7(c), the grantee (and the grantee’s legal representative) shall not have any rights under any Stock Appreciation Right, and the Company shall not be obligated to pay or deliver any cash, Common Stock or any combination thereof (or have any other obligation or liability) under any Stock Appreciation Right, if the Committee shall determine that (i) the employment of the grantee with the Company or any Subsidiary has been terminated for cause or (ii) the grantee has engaged or may engage in employment or activities competitive with the Company or any Subsidiary or contrary, in the opinion of the Committee, to the best interests of the Company or any Subsidiary. In the event of such determination, the grantee (and the grantee’s legal representative) shall have no right under any Stock Appreciation Right regardless of whether the grantee (or the grantee’s legal representative) shall have delivered a notice of exercise prior to the Committee’s making of such determination. Any Stock Appreciation Right may be terminated entirely by the Committee at the time of or at any time subsequent to a determination by the Committee under this Section 7(c) which has the effect of eliminating the Company’s obligations under such Stock Appreciation Right.
In the event that a grantee of a Stock Appreciation Right ceases to be employed either by the Company or by a Subsidiary by reason of such grantee’s Disability, prior to the expiration of a Stock Appreciation Right and without such grantee’s having fully exercised such Stock Appreciation Right, such grantee or such grantee’s legal representative shall have the right to exercise such Stock Appreciation Right during its term within a period of six months after such termination of employment to the extent that such Stock Appreciation Right was exercisable at the time of such termination or within such other period and subject to such other terms and conditions as may be specified by the Committee.
In the event that a grantee of a Stock Appreciation Right ceases to be employed either by the Company or by a Subsidiary by reason of such grantee’s death, prior to the expiration of a Stock Appreciation Right and without such grantee’s having fully exercised such Stock Appreciation Right, the personal representative of the grantee’s estate or the person who acquired the right to exercise such Stock Appreciation Right by bequest or inheritance from such grantee shall have the right to exercise such Stock Appreciation Right during its term within a period of twelve months after the date of such grantee’s death to the extent that such Stock Appreciation Right was exercisable at the time of such death or within such other period and subject to such other terms and conditions as may be specified by the Committee.
The foregoing provisions of this Section 7(c) shall not be applicable to non‑employee directors of the Company.
66 | 2020 Proxy Statement
|
|
|
Appendix A
(d) Rights Upon Termination of Service as a Director. Unless the applicable agreement provides otherwise, if a grantee of a Stock Appreciation Right who is a non‑employee director of the Company ceases to be a director of the Company for any reason other than retirement from the Board under circumstances described in the following paragraph of this Section 7(d) or death, then each outstanding but unexercised Stock Appreciation Right held by such grantee shall continue to be exercisable only to the extent that it was exercisable at the time that such grantee ceased to be a director of the Company and only until the earlier of (i) three months after such grantee ceased to be a director of the Company or (ii) the expiration of the term of such Stock Appreciation Right.
Unless the applicable agreement provides otherwise, if the grantee of a Stock Appreciation Right who is a non‑employee director of the Company ceases to be a director of the Company (other than by reason of death) and at the time of such occurrence (the “Retirement Date”) is at least age 65 with ten or more years of service as a director of the Company or is at least age 70 with five or more years of service as a director of the Company, then each outstanding but unexercised Stock Appreciation Right held by such grantee on the Retirement Date shall continue to be or become exercisable in accordance with its terms until the earlier of (i) five years after the Retirement Date or (ii) the expiration of the term of such Stock Appreciation Right.
Unless the applicable agreement provides otherwise, if the grantee of a Stock Appreciation Right who is a non‑employee director of the Company dies, then each outstanding but unexercised Stock Appreciation Right which had been held by such grantee for at least twelve months as of the date of such grantee’s death automatically shall become exercisable in full (if not already exercisable) upon such grantee’s death. Each outstanding but unexercised Stock Appreciation Right which becomes exercisable pursuant to the preceding sentence and each outstanding but unexercised Stock Appreciation Right held by such grantee which was exercisable on the date of such grantee’s death may be exercised by the legal representative of such grantee’s estate or by the beneficiaries of such estate to whom such Stock Appreciation Right is distributed until the earlier of (i) three years after the date of such grantee’s death or (ii) the expiration of the term of such Stock Appreciation Right.
The foregoing provisions of this Section 7(d) shall be applicable only to non‑employee directors of the Company.
8. Performance Unit Awards. Performance Unit Awards shall entitle the grantees thereof to receive future payments based upon and subject to the achievement of preestablished long‑term performance targets and shall be evidenced by agreements in such form as the Committee shall approve from time to time. The agreements shall contain in substance the following terms and conditions and may contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem appropriate:
(a) Performance Period. The Committee shall establish with respect to each Performance Unit Award a performance period of not fewer than two years nor more than five years.
(b) Unit Value. The Committee shall establish with respect to each Performance Unit Award a value for each unit which shall not change thereafter or which may vary thereafter on the basis of criteria specified by the Committee.
(c) Performance Targets. The Committee shall establish with respect to each Performance Unit Award maximum and minimum performance targets to be achieved during the applicable performance period. The achievement of the maximum targets shall entitle a grantee to payment with respect to the full value of a Performance Unit Award. The achievement of less than the maximum targets, but in excess of the minimum targets, shall entitle a grantee to payment with respect to a portion of a Performance Unit Award according to the level of achievement of the applicable targets as specified by the Committee.
|
|
2020 Proxy Statement | 67
|
Appendix A
(d) Performance Measures. Performance targets established by the Committee shall relate to corporate, division, subsidiary, group, or unit performance in terms of financial criteria or performance goals or such other measures or standards of performance as the Committee may determine. Multiple targets may be used and may have the same or different weighting, and the targets may relate to absolute performance or relative performance measured against other companies, businesses, or indexes.
(e) Adjustments. At any time prior to the payment of a Performance Unit Award, the Committee may adjust previously established performance targets or other terms and conditions of such Performance Unit Award, including the Company’s or another company’s financial performance for Plan purposes. Such adjustments shall be made to reflect major unforeseen events or changes in circumstances affecting the Company such as but not limited to changes in laws, regulations or accounting principles, mergers, acquisitions or divestitures, or other extraordinary, unusual, or nonrecurring items or events.
(f) Payment of Performance Unit Awards. Upon the conclusion of each performance period, the Committee shall determine the extent to which the applicable performance targets have been attained and any other terms and conditions have been satisfied for such period. The Committee shall determine what, if any, payment is due on a Performance Unit Award and, subject to the limitations set forth in Section 4, whether such payment shall be made in cash, in shares of Common Stock (valued at their then Fair Market Value), or in a combination thereof. Payment of a Performance Unit Award shall be made in a lump sum or in installments, as determined by the Committee, commencing as promptly as practicable after the end of the performance period unless such payment is deferred upon such terms and conditions as may be specified by the Committee.
(g) Termination of Employment. In the event that a grantee of a Performance Unit Award ceases to be employed either by the Company or by a Subsidiary for any reason other than such grantee’s death or Disability, any rights of such grantee under any Performance Unit Award then in effect whose performance period has not ended shall terminate immediately; provided, that the Committee may authorize the partial payment of any such Performance Unit Award if the Committee determines such action to be equitable.
In the event that a grantee of a Performance Unit Award ceases to be employed either by the Company or by a Subsidiary by reason of such grantee’s death or Disability, any rights of such grantee under any Performance Unit Award then in effect whose performance period has not ended shall terminate immediately; provided, that the Committee may authorize the payment to such grantee or such grantee’s legal representative of all or any portion of such Performance Unit Award to the extent earned under the applicable performance targets, even though the applicable performance period has not ended, upon such terms and conditions as may be specified by the Committee.
9. Restricted Stock Awards. Restricted Stock Awards shall (i) consist of shares of Common Stock restricted against transfer, (ii) be subject to a substantial risk of forfeiture and to other terms and conditions intended to further the purpose of the Plan as the Committee may determine, and (iii) be evidenced by agreements in such form as the Committee shall approve from time to time. The agreements shall contain in substance the following terms and conditions and may contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem appropriate:
(a) Restriction Period. The Common Stock covered by Restricted Stock Awards shall be subject to the applicable restrictions established by the Committee over such period as the Committee shall determine. Restricted Stock Awards also may be subject to the attainment of one or more preestablished performance objectives which relate to corporate, subsidiary, division, group, or unit performance in terms of objective financial criteria or performance goals; provided, that any such preestablished financial criteria or performance goals subsequently may be adjusted by the Committee in order to take into account unforeseen events or changes in circumstances affecting the Company such as but not limited to changes in laws, regulations or accounting principles, mergers, acquisitions or divestitures, or other extraordinary, unusual, or nonrecurring items or events.
68 | 2020 Proxy Statement
|
|
|
Appendix A
(b) Restriction upon Transfer. Shares of Common Stock covered by Restricted Stock Awards may not be sold, assigned, transferred, exchanged, pledged, hypothecated, or otherwise encumbered, except as provided in the Plan or in any Restricted Stock Award agreement entered into between the Company and a grantee, during the restriction period applicable to such shares. Notwithstanding the foregoing provisions of this Section 9(b), and except as otherwise provided in the Plan or the applicable Restricted Stock Award agreement, a grantee of a Restricted Stock Award shall have all of the other rights of a holder of Common Stock including but not limited to the right to receive dividends and the right to vote such shares.
(c) Payment. The Committee shall determine the amount, form and time of payment, if any, that shall be required from the grantee of a Restricted Stock Award in consideration of the issuance and delivery of the shares of Common Stock covered by such Restricted Stock Award.
(d) Certificates. Each certificate issued in respect of shares of Common Stock covered by a Restricted Stock Award shall be registered in the name of the grantee and shall bear substantially the following legend (in addition to any other legends which may be appropriate):
“This certificate and the shares of stock represented hereby are subject to the terms and conditions (including forfeiture provisions and restrictions against transfer) contained in the CSG Systems International, Inc. 2005 Stock Incentive Plan and a Restricted Stock Award Agreement entered into between the registered owner and CSG Systems International, Inc. Release from such terms and conditions may be obtained only in accordance with the provisions of such Plan and Agreement, a copy of each of which is on file in the office of the Secretary of CSG Systems International, Inc.”
The Committee may require the grantee of a Restricted Stock Award to enter into an escrow agreement providing that the certificates representing the shares covered by such Restricted Stock Award will remain in the physical custody of an escrow agent until all restrictions are removed or expire and may require that the certificates held in such escrow be accompanied by a stock power, endorsed in blank by the grantee, relating to the Common Stock covered by such certificates. The Company also may use a book‑entry system of uncertificated shares to administer grants of Restricted Stock Awards and to effect any withholding required by Section 15.
(e) Lapse of Restrictions. The Committee may provide for the lapse of restrictions applicable to Common Stock subject to Restricted Stock Awards in installments and may waive such restrictions in whole or in part based upon such factors and such circumstances as the Committee shall determine. Upon the lapse of such restrictions, subject to the provisions of Section 15, certificates for shares of Common Stock, free of the restrictive legend set forth in Section 9(d), shall be issued to the grantee or the grantee’s legal representative automatically in the case of certificated shares or upon the request of the grantee in the case of uncertificated shares. The Committee shall have authority to accelerate the expiration of the applicable restriction period with respect to all or any portion of the shares of Common Stock covered by a Restricted Stock Award.
(f) Termination of Employment or Service as a Director. If a grantee of a Restricted Stock Award ceases to be employed either by the Company or by a Subsidiary or to serve as a director of the Company for any reason, then any rights of such grantee with respect to shares of Common Stock that remain subject to restrictions under such Restricted Stock Award shall terminate immediately, and any shares of Common Stock covered by a Restricted Stock Award with unlapsed restrictions shall be subject to reacquisition by the Company upon the terms set forth in the applicable agreement with such grantee. The Committee may provide for complete or partial exceptions to such employment or service requirement if the Committee determines such action to be equitable.
|
|
2020 Proxy Statement | 69
|
Appendix A
10. Restricted Stock Unit Awards. Restricted Stock Unit Awards shall entitle the grantees thereof to receive future payments from the Company either in shares of Common Stock or in cash or in a combination of Common Stock and cash at such time or times and on such terms as the Committee shall approve from time to time. The following provisions shall be applicable to Restricted Stock Unit Awards:
(a) Award Agreement. Each Restricted Stock Unit Award shall be evidenced by an agreement, in a form approved by the Committee, which sets forth the number of Restricted Stock Units covered by such Award, the time or times when such Restricted Stock Units will vest in the grantee, and such other terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem appropriate.
(b) Payment of Award. Upon the vesting of a Restricted Stock Unit, the Company shall pay the amount of such Restricted Stock Units to the grantee either (i) in shares of Common Stock on the basis of one share of Common Stock for each vested Restricted Stock Unit, (ii) in cash in an amount equal to the Fair Market Value on the vesting date of one share of Common Stock for each vested Restricted Stock Unit, or (iii) in a combination of cash and shares of Common Stock as the Committee in its discretion shall determine with respect to such Award either in the applicable Award agreement or at the time of the vesting of such Restricted Stock Unit.
(c) Termination of Employment or Service as a Director. If a grantee of a Restricted Stock Unit Award ceases to be employed either by the Company or by a Subsidiary or to serve as a director of the Company for any reason, then any rights of such grantee with respect to the unvested portion of such Restricted Stock Unit Award shall terminate immediately. The Committee may provide for complete or partial exceptions to such employment or service requirement if the Committee determines such action to be equitable.
(d) Performance Objectives. Restricted Stock Unit Awards may be subject to the attainment of one or more preestablished performance objectives which relate to corporate, subsidiary, division, group, or unit performance in terms of objective financial criteria or performance goals; provided, that any such preestablished financial criteria or performance goals subsequently may be adjusted by the Committee in order to take into account unforeseen events or changes in circumstances affecting the Company such as but not limited to changes in laws, regulations or accounting principles, mergers, acquisitions or divestitures, or other extraordinary, unusual, or nonrecurring items or events.
11. Stock Bonus Awards. The Committee may grant a Stock Bonus Award to an eligible grantee under the Plan based upon corporate, division, subsidiary, group, or unit performance in terms of preestablished objective financial criteria or performance goals or such other measures or standards of performance (including but not limited to performance already accomplished) as the Committee may determine; provided, that any such preestablished financial criteria or performance goals subsequently may be adjusted in order to take into account unforeseen events or changes in circumstances affecting the Company such as but not limited to changes in laws, regulations or accounting principles, mergers, acquisitions or divestitures, or other extraordinary, unusual, or nonrecurring items or events.
If appropriate in the sole discretion of the Committee, Stock Bonus Awards shall be evidenced by agreements in such form as the Committee shall approve from time to time. In addition to any applicable performance goals or standards and subject to the terms of the Plan, shares of Common Stock which are the subject of a Stock Bonus Award may be (i) subject to additional restrictions (including but not limited to restrictions on transfer) or (ii) granted directly to a grantee free of any restrictions, as the Committee shall deem appropriate.
12. General Restrictions. Each award or grant under the Plan shall be subject to the requirement that if at any time the Committee shall determine that (i) the listing, registration, or qualification of the shares of Common Stock subject or related thereto upon any securities exchange or under any state or federal law, (ii) the consent or approval of any governmental regulatory body, or (iii) an agreement by the grantee of an award or grant with respect to the disposition of the shares of Common Stock subject or related thereto is necessary or desirable as a condition of, or in connection with, such award or grant or the issuance or purchase of shares of Common Stock thereunder, then such award or grant may not be consummated and any rights thereunder may not be exercised in whole or in part unless such listing, registration,
70 | 2020 Proxy Statement
|
|
|
Appendix A
qualification, consent, approval, or agreement shall have been effected or obtained upon conditions acceptable to the Committee. Awards or grants under the Plan shall be subject to such additional terms and conditions, not inconsistent with the Plan, as the Committee in its sole discretion deems necessary or desirable, including but not limited to such terms and conditions as are necessary to enable a grantee to avoid any short‑swing profit recapture liability under Section 16 of the Exchange Act.
13. Single or Multiple Agreements. Multiple forms of awards or grants or combinations thereof may be evidenced either by a single agreement or by multiple agreements, as determined by the Committee.
14. Rights of a Stockholder. Unless otherwise provided by the Plan, the grantee of any award or grant under the Plan shall have no rights as a stockholder of the Company with respect to the shares of Common Stock subject or related to such award or grant unless and until certificates for such shares of Common Stock are issued to such grantee or until uncertificated shares have been credited to an account established for such grantee.
15. No Right to Continue Employment or Service as a Director. Nothing in the Plan or in any agreement entered into pursuant to the Plan shall confer upon any grantee who is an employee of the Company or any Subsidiary the right to continue in the employment of the Company or any Subsidiary or affect any right which the Company or any Subsidiary may have to terminate the employment of such grantee with or without cause. Nothing in the Plan or in any agreement entered into pursuant to the Plan shall confer upon any grantee who is a non‑employee director of the Company the right to continue to serve as a director of the Company.
16. Withholding. The Company’s obligation to (i) deliver shares of Common Stock or pay cash upon the exercise of any Stock Option or Stock Appreciation Right, (ii) deliver shares of Common Stock or pay cash in payment of any Performance Unit Award, (iii) deliver stock certificates upon the vesting of any Restricted Stock Award, (iv) deliver shares of Common Stock or pay cash upon the vesting of any Restricted Stock Unit Award, or (v) deliver shares of Common Stock upon the grant of any Stock Bonus Award shall be subject to applicable federal, state, and local tax withholding requirements. In the discretion of the Committee, amounts required to be withheld for taxes may or must be paid by the grantee in cash or shares of Common Stock (either through the surrender of previously held shares of Common Stock or the withholding of shares of Common Stock otherwise issuable or deliverable upon the exercise, payment or vesting of such Stock Option, Stock Appreciation Right, or Award) having a Fair Market Value equal to the required tax withholding amount and upon such other terms and conditions as the Committee shall determine; provided, that any election by a grantee subject to Section 16(b) of the Exchange Act to pay any tax withholding in shares of Common Stock shall be subject to and must comply with any applicable rules under Section 16(b) of the Exchange Act.
17. Indemnification. No member of the Board or the Committee, and no officer or employee of the Company or a Subsidiary acting on behalf of the Board or the Committee, shall be personally liable for any action, determination, or interpretation taken or made in good faith with respect to the Plan or any award or option granted under the Plan; and all members of the Board or the Committee and each and any officer or employee of the Company or any Subsidiary acting on their behalf shall, to the fullest extent permitted by law, be fully indemnified and held harmless by the Company in respect of any such action, determination or interpretation.
18. Non‑Assignability. No award or grant under the Plan shall be assignable or transferable by the recipient thereof except by will, by the laws of descent and distribution, or, in the case of awards or grants other than Incentive Stock Options, pursuant to a qualified domestic relations order. No right or benefit under the Plan shall be liable for the debts, liabilities, or alimony or child support obligations of the person entitled to such right or benefit, either by assignment, attachment, or any other method, and shall not be subject to be taken by the creditors or alimony or child support obligees of the person entitled to such right or benefit by any process whatsoever.
19. Nonuniform Determinations. The Committee’s determinations under the Plan (including but not limited to determinations of the persons to receive awards or grants, the form, amount, and timing of such awards or grants, the terms and provisions of such awards or grants and the agreements evidencing them, and the establishment of values and performance targets) need not be uniform and may be made by the Committee selectively among the persons who receive, or are eligible to receive, awards or grants under the Plan, whether or not such persons are similarly situated.
|
|
2020 Proxy Statement | 71
|
Appendix A
20. Adjustments. In the event of any change in the outstanding shares of Common Stock, by reason of a stock dividend or distribution, stock split, recapitalization, merger, reorganization, consolidation, split‑up, spin‑ off, combination of shares, exchange of shares, or other change in corporate structure affecting the Common Stock, the Committee shall make appropriate adjustments in (a) the aggregate number of shares of Common Stock (i) reserved for issuance under the Plan, (ii) for which grants or awards may be made to an individual grantee, and (iii) covered by outstanding awards and grants denominated in shares or units of Common Stock, (b) the exercise or other applicable price related to outstanding awards or grants, and (c) the appropriate Fair Market Value and other price determinations relevant to outstanding awards or grants and shall make such other adjustments not inconsistent with the provisions of Section 22 as may be equitable under the circumstances; provided, that the number of shares subject to any award or grant always shall be a whole number.
21. Terms of Payment. Subject to any other applicable provisions of the Plan and to any applicable laws, whenever payment by a grantee is required with respect to shares of Common Stock which are the subject of an award or grant under the Plan, the Committee shall determine the time, form, and manner of such payment, including but not limited to lump‑sum payments and installment payments upon such terms and conditions as the Committee may prescribe. Installment payment obligations of a grantee may be evidenced by full‑recourse, limited‑recourse, or non‑recourse promissory notes or other instruments, with or without interest and with or without collateral or other security as the Committee may determine.
22. Termination and Amendment. The Board may terminate the Plan or amend the Plan or any provision thereof at any time, including but not limited to amendments to the Plan necessary to comply with the requirements of Section 16(b) of the Exchange Act, Section 422 of the Code, or regulations issued under any of such statutory provisions. The termination or any amendment of the Plan shall not, without the consent of a grantee, adversely affect such grantee’s rights under an award or grant previously made to such grantee under the Plan. The Committee may amend the terms of any award or grant previously made under the Plan, prospectively or retroactively; but, subject to the provisions of Section 20, no such amendment shall, except as otherwise expressly permitted by the Plan, adversely affect the rights of the grantee of such award or grant without such grantee’s consent. Except in connection with a transaction involving the Common Stock (such as but not limited to a stock dividend, stock split, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, split‑up, spin‑off, combination of shares, or exchange of shares), the Committee may not, without stockholder approval, (i) amend the terms of an outstanding Stock Option so as to reduce the exercise price of such Stock Option, (ii) amend the terms of a Stock Appreciation Right so as to reduce the specified stock price applicable to such Stock Appreciation Right at the time of its grant, or (iii) cancel an outstanding Stock Option or Stock Appreciation Right in exchange for cash, other awards, Stock Options with an exercise price that is less than the exercise price of the original Stock Option, or Stock Appreciation Rights with a specified stock price that is less than the specified stock price applicable to the original Stock Appreciation Right. Notwithstanding the foregoing provisions of this Section 22, stockholder approval of any action referred to in this Section 22 shall be required whenever necessary to satisfy the applicable requirements of Section 16(b) of the Exchange Act, Section 422 of the Code, or any regulations issued under any of such statutory provisions or the applicable requirements of any market or exchange on which shares of the Common Stock are listed or traded.
23. Severability. With respect to participants subject to Section 16 of the Exchange Act, (i) the Plan is intended to comply with all applicable conditions of Rule 16b‑3 or any successor to such rule, (ii) all transactions involving grantees who are subject to Section 16(b) of the Exchange Act are subject to such conditions, regardless of whether the conditions are expressly set forth in the Plan, and (iii) any provision of the Plan that is contrary to a condition of Rule 16b‑3 shall not apply to grantees who are subject to Section 16(b) of the Exchange Act. If any of the terms or provisions of the Plan, or awards or grants made under the Plan, conflict with the requirements of Section 422 of the Code with respect to awards or grants intended to be subject to or governed by Section 422 of the Code, as the case may be, then such terms or provisions shall be deemed to be inoperative to the extent they so conflict with the requirements of Section 422 of the Code, as the case may be. With respect to an Incentive Stock Option, if the Plan does not contain any provision required to be included in the Plan under Section 422 of the Code (as amended from time to time) or any successor to such section, then such provision shall be deemed to be incorporated in the Plan with the same force and effect as if such provision had been expressly set out in the Plan.
72 | 2020 Proxy Statement
|
|
|
Appendix A
24. Effect on Other Plans. Participation in the Plan shall not affect the eligibility of an employee or a non‑employee director of the Company to participate in any other benefit or incentive plan of the Company or any Subsidiary. Any awards made pursuant to the Plan shall not be taken into account in determining the benefits provided or to be provided under any other plan of the Company or any Subsidiary unless otherwise specifically provided in such other plan.
25. Term of Plan. The Plan as amended and restated shall become effective on the date of its approval by the stockholders of the Company and shall terminate for purposes of further grants on the first to occur of (i) May 17, 2028, or (ii) the effective date of the termination of the Plan by the Board pursuant to Section 22. No awards or options may be granted under the Plan after the termination of the Plan, but such termination shall not affect any awards or options outstanding under the Plan at the time of such termination or the authority of the Committee to continue to administer the Plan apart from the making of further grants. Notwithstanding anything in the Plan to the contrary, any award granted under the Plan prior to January 1, 2018, that was intended to constitute “performance-based compensation” under Section 162(m) of the Code shall, to the extent the Committee determines necessary to preserve the deductibility of compensation paid under such award, be administered in accordance with the applicable requirements of Section 162(m) of the Code.
26. Governing Law. The Plan shall be governed by and construed in accordance with the laws of Delaware.
27. Section 409A.
(a) Time and Form of Payment. Notwithstanding anything contained in the Plan or in an award agreement to the contrary, the time and form of payment of an award that is subject to the limitations imposed by Section 409A of the Code shall be set forth in the applicable award agreement on or before the time at which the grantee of the award obtains a legally binding right to the award (or such other time permitted under Section 409A of the Code) and such time and form of payment shall comply with the requirements of Section 409A of the Code.
(b) Delay in Payment. Notwithstanding anything contained in the Plan or an award agreement to the contrary, if the grantee of the award is deemed by the Company at the time of such grantee’s “separation from service” with the Company to be a “specified employee” as determined under Section 409A of the Code, any nonqualified deferred compensation to which such grantee is entitled under the Plan in connection with such separation from service shall not be paid or commence payment until the date which is the first business day following the six‑month period after such grantee’s separation from service (or if earlier, such grantee’s death). Such delay in payment shall only be effected with respect to each separate payment to the extent required to avoid adverse tax treatment to such grantee under Section 409A of the Code. Any compensation which would have otherwise been paid during the delay period (whether in a lump sum or in installments) in the absence of this Section 27 shall be paid to such grantee or such grantee’s Beneficiary in a lump‑sum payment on the first business day following the expiration of the delay period.
(c) Amendments. Notwithstanding anything in the Plan to the contrary, the Plan and awards granted under the Plan are intended to be eligible for certain regulatory exceptions to the limitations of, or to comply with, the requirements of Section 409A of the Code. The Committee, in the exercise of its sole discretion and without the consent of the grantee of an award under the Plan, may amend or modify the terms of an award in any manner and delay the payment of any amounts payable pursuant to an award to the minimum extent necessary to reasonably comply with the requirements of Section 409A of the Code, provided that the Company shall not be required to assume any increased economic burden. No action so taken by the Committee with respect to the requirements of Section 409A of the Code shall be deemed to adversely affect the rights of a grantee of an award under the Plan with respect to an award or to require the consent of such grantee. The Committee reserves the right to make additional changes to the Plan and awards from time to time to the extent it deems necessary with respect to Section 409A of the Code.
|
|
2020 Proxy Statement | 73
|
CSG SYSTEMS INTERNATIONAL, INC. 6175 S. WILLOW DRIVE GREENWOOD VILLAGE, CO 80111 VOTE BY INTERNET Before The Meeting - Go to www.proxyvote.com Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time on May 20, 2020. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During The Meeting - Go to www.virtualshareholdermeeting.com/CSGS2020 You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time on May 20, 2020. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: D06681-P33304 KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY CSG SYSTEMS INTERNATIONAL, INC. The Board of Directors recommends you vote FOR the following: 1. Election of Directors Nominees: For Against Abstain 1a. David G. Barnes 1b. Marwan H. Fawaz 1c. Dr. Rajan Naik 1d. Haiyan Song The Board of Directors recommends you vote FOR proposals 2, 3 and 4. For Against Abstain 2. To approve, on an advisory basis, the compensation of our named executive officers. 3. To approve an amendment and restatement of our Amended and Restated 2005 Stock Incentive Plan. 4. To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal 2020 NOTE: Any other business that properly comes before the meeting or any adjournment or postponement of the meeting. Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Dat
e
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement and Form 10-K are available at www.proxyvote.com. D06682-P33304 CSG SYSTEMS INTERNATIONAL, INC. 2020 Annual Meeting of Stockholders May 21, 2020 8:00 AM CDT This proxy is solicited by the Board of Directors The undersigned hereby constitutes and appoints Bret C. Griess and Gregory L. Cannon, and each or either of them, as attorneys and proxies of the undersigned, with full power of substitution to each of them, to vote all shares of stock of CSG Systems International, Inc. (the "Company") standing in the name of the undersigned at the 2020 Annual Meeting of Stockholders of the Company to be held via live webcast at www.virtualshareholdermeeting.com/CSGS2020, at 8:00 a.m. (Central Daylight Time) on May 21, 2020, and at any adjournments or postponements of the meeting, on the matters set forth on the reverse side hereof and in their discretion on any other matters that properly may come before such meeting or any adjournments thereof. THIS PROXY, WHEN PROPERLY SIGNED, WILL BE VOTED AS SPECIFIED. IF NO SPECIFICATION IS GIVEN, THIS PROXY WILL BE IN ACCORDANCE WITH THE BOARD OF DIRECTORS' RECOMMENDATIONS. The undersigned hereby ratifies and confirms that either of such attorneys and proxies, or their substitutes, may do or cause to be done by virtue hereof and acknowledges receipt of the Notice of the 2020 Annual Meeting of Stockholders of the Company to be held on May 21, 2020, the Proxy Statement of the Company for such Annual Meeting, and the 2019 Annual Report on Form 10-K of the Company. Continued and to be signed on reverse side